{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:34:25Z","timestamp":1794335665765,"version":"4.9.0"},"reference-count":413,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DRK-Blood Donation Service Baden-W\u00fcrttemberg\u2014Hessen, Mannheim; BSMU Strategic Academic Leadership Program PRIORITY-2030"},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202306320511"],"award-info":[{"award-number":["202306320511"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"abstract":"<jats:title>\u0410bstract<\/jats:title>\n                  <jats:p>With increasing incidence and geography, cancer is one of the leading causes of death, reduced quality of life and disability worldwide. Principal progress in the development of new anticancer therapies, in improving the efficiency of immunotherapeutic tools, and in the personification of conventional therapies needs to consider cancer-specific and patient-specific programming of innate immunity. Intratumoral TAMs and their precursors, resident macrophages and monocytes, are principal regulators of tumor progression and therapy resistance. Our review summarizes the accumulated evidence for the subpopulations of TAMs and their increasing number of biomarkers, indicating their predictive value for the clinical parameters of carcinogenesis and therapy resistance, with a focus on solid cancers of non-infectious etiology. We present the state-of-the-art knowledge about the tumor-supporting functions of TAMs at all stages of tumor progression and highlight biomarkers, recently identified by single-cell and spatial analytical methods, that discriminate between tumor-promoting and tumor-inhibiting TAMs, where both subtypes express a combination of prototype M1 and M2 genes. Our review focuses on novel mechanisms involved in the crosstalk among epigenetic, signaling, transcriptional and metabolic pathways in TAMs. Particular attention has been given to the recently identified link between cancer cell metabolism and the epigenetic programming of TAMs by histone lactylation, which can be responsible for the unlimited protumoral programming of TAMs. Finally, we explain how TAMs interfere with currently used anticancer therapeutics and summarize the most advanced data from clinical trials, which we divide into four categories: inhibition of TAM survival and differentiation, inhibition of monocyte\/TAM recruitment into tumors, functional reprogramming of TAMs, and genetic enhancement of macrophages.<\/jats:p>","DOI":"10.1038\/s41423-024-01232-z","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T06:26:09Z","timestamp":1731047169000},"page":"1376-1409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":183,"title":["Targeting of TAMs: can we be more clever than cancer cells?"],"prefix":"10.1038","volume":"21","author":[{"given":"Julia","family":"Kzhyshkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-8466","authenticated-orcid":false,"given":"Jiaxin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5758-7330","authenticated-orcid":false,"given":"Irina","family":"Larionova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"1232_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1232_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, Chen H-D, Yu Y-W, Li N, Chen W-Q. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134:783\u201391.","journal-title":"Chin Med J (Engl)"},{"key":"1232_CR3","first-page":"1","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner RC, Sterner RM. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J 2021 11:4. 2021;11:1\u201311.","journal-title":"Blood Cancer J 2021 11:4"},{"key":"1232_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1212476","volume":"14","author":"R Rui","year":"2023","unstructured":"Rui R, Zhou L, He S. Cancer immunotherapies: advances and bottlenecks. Front Immunol. 2023;14:1212476.","journal-title":"Front Immunol"},{"key":"1232_CR5","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.cell.2021.02.011","volume":"184","author":"M Dougan","year":"2021","unstructured":"Dougan M, Luoma AM, Dougan SK, Wucherpfennig KW. Understanding and treating the inflammatory adverse events of cancer immunotherapy. Cell. 2021;184:1575\u201388.","journal-title":"Cell"},{"key":"1232_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103194","volume":"157","author":"EN Imyanitov","year":"2021","unstructured":"Imyanitov EN, Iyevleva AG, Levchenko EV. Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives. Crit Rev Oncol Hematol. 2021;157:103194.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1232_CR7","doi-asserted-by":"publisher","first-page":"13129","DOI":"10.3390\/ijms232113129","volume":"23","author":"E Imyanitov","year":"2022","unstructured":"Imyanitov E, Sokolenko A. Integrative Genomic Tests in Clinical Oncology. Int J Mol Sci. 2022;23:13129.","journal-title":"Int J Mol Sci"},{"key":"1232_CR8","doi-asserted-by":"publisher","first-page":"12797","DOI":"10.3390\/ijms241612797","volume":"24","author":"G Rafikova","year":"2023","unstructured":"Rafikova G, Gilyazova I, Enikeeva K, Pavlov V, Kzhyshkowska J. Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers. Int J Mol Sci. 2023;24:12797.","journal-title":"Int J Mol Sci"},{"key":"1232_CR9","doi-asserted-by":"crossref","unstructured":"Larionova I, Tuguzbaeva G, Ponomaryova A, Stakheyeva M, Cherdyntseva N, Pavlov V, et al. Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers. Front Oncol. 2020;10:566511.","DOI":"10.3389\/fonc.2020.566511"},{"key":"1232_CR10","doi-asserted-by":"publisher","unstructured":"Larionova I, Kazakova E, Patysheva M, Kzhyshkowska J. Transcriptional, Epigenetic and Metabolic Programming of Tumor-Associated Macrophages. Cancers (Basel) 2020;12. https:\/\/doi.org\/10.3390\/cancers12061411.","DOI":"10.3390\/cancers12061411"},{"key":"1232_CR11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","volume":"186","author":"DJ Kloosterman","year":"2023","unstructured":"Kloosterman DJ, Akkari L. Macrophages at the interface of the co-evolving cancer ecosystem. Cell. 2023;186:1627\u201351.","journal-title":"Cell"},{"key":"1232_CR12","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jhep.2020.05.004","volume":"73","author":"Z-P Peng","year":"2020","unstructured":"Peng Z-P, Jiang Z-Z, Guo H-F, Zhou M-M, Huang Y-F, Ning W-R, et al. Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma. J Hepatol. 2020;73:906\u201317.","journal-title":"J Hepatol"},{"key":"1232_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.994319","volume":"13","author":"M Patysheva","year":"2022","unstructured":"Patysheva M, Frolova A, Larionova I, Afanas\u2019ev S, Tarasova A, Cherdyntseva N, et al. Monocyte programming by cancer therapy. Front Immunol. 2022;13:994319.","journal-title":"Front Immunol"},{"key":"1232_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1080501","volume":"13","author":"I Larionova","year":"2023","unstructured":"Larionova I, Patysheva M, Iamshchikov P, Kazakova E, Kazakova A, Rakina M, et al. PFKFB3 overexpression in monocytes of patients with colon but not rectal cancer programs pro-tumor macrophages and is indicative for higher risk of tumor relapse. Front Immunol. 2023;13:1080501.","journal-title":"Front Immunol"},{"key":"1232_CR15","doi-asserted-by":"crossref","unstructured":"Patysheva M, Larionova I, Stakheyeva M, Grigoryeva E, Iamshchikov P, Tarabanovskaya N, et al. Effect of Early-Stage Human Breast Carcinoma on Monocyte Programming. Front Oncol 2022;11:800235.","DOI":"10.3389\/fonc.2021.800235"},{"key":"1232_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1414716","volume":"15","author":"I Larionova","year":"2024","unstructured":"Larionova I, Iamshchikov P, Kazakova A, Rakina M, Menyalo M, Enikeeva K, et al. Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma. Front Immunol. 2024;15:1414716.","journal-title":"Front Immunol"},{"key":"1232_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40164-021-00252-z","volume":"10","author":"S Zhu","year":"2021","unstructured":"Zhu S, Yi M, Wu Y, Dong B, Wu K. Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies. Exp Hematol Oncol. 2021;10:60.","journal-title":"Exp Hematol Oncol"},{"key":"1232_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11503-2","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li S, Liu F, Yang K. Role of CD68 in tumor immunity and prognosis prediction in pan-cancer. Sci Rep. 2022;12:7844.","journal-title":"Sci Rep."},{"key":"1232_CR19","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1158\/1078-0432.CCR-06-2073","volume":"13","author":"J Forssell","year":"2007","unstructured":"Forssell J, \u04e6berg A, Henriksson ML, Stenling R, Jung A, Palmqvist R. High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer. Clin Cancer Res. 2007;13:1472\u20139.","journal-title":"Clin Cancer Res"},{"key":"1232_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00384-020-03593-z","volume":"35","author":"J Li","year":"2020","unstructured":"Li J, Li L, Li Y, Long Y, Zhao Q, Ouyang Y, et al. Tumor-associated macrophage infiltration and prognosis in colorectal cancer: systematic review and meta-analysis. Int J Colorectal Dis. 2020;35:1203\u201310.","journal-title":"Int J Colorectal Dis"},{"key":"1232_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10735-013-9520-9","volume":"44","author":"M Gulubova","year":"2013","unstructured":"Gulubova M, Ananiev J, Yovchev Y, Julianov A, Karashmalakov A, Vlaykova T. The density of macrophages in colorectal cancer is inversely correlated to TGF-\u03b21 expression and patients\u2019 survival. J Mol Histol. 2013;44:679\u201392.","journal-title":"J Mol Histol"},{"key":"1232_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-8-13","volume":"8","author":"Q Zhou","year":"2010","unstructured":"Zhou Q, Peng R-Q, Wu X-J, Xia Q, Hou J-H, Ding Y, et al. The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med. 2010;8:13.","journal-title":"J Transl Med"},{"key":"1232_CR23","first-page":"4291","volume":"22","author":"Y Nakayama","year":"2002","unstructured":"Nakayama Y, Nagashima N, Minagawa N, Inoue Y, Katsuki T, Onitsuka K, et al. Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer. Anticancer Res. 2002;22:4291\u20136.","journal-title":"Anticancer Res"},{"key":"1232_CR24","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1245\/s10434-017-5812-8","volume":"24","author":"MJ Cavnar","year":"2017","unstructured":"Cavnar MJ, Turcotte S, Katz SC, Kuk D, G\u00f6nen M, Shia J, et al. Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome. Ann Surg Oncol. 2017;24:1835\u201342.","journal-title":"Ann Surg Oncol"},{"key":"1232_CR25","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s13402-024-00926-w","volume":"47","author":"U Majid","year":"2024","unstructured":"Majid U, Bergsland CH, Sveen A, Bruun J, Eilertsen IA, B\u00e6kkevold ES, et al. The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration. Cell Oncol. 2024;47:1267\u201376.","journal-title":"Cell Oncol"},{"key":"1232_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ajpath.2017.10.025","volume":"188","author":"K Esbona","year":"2018","unstructured":"Esbona K, Yi Y, Saha S, Yu M, Van Doorn RR, Conklin MW, et al. The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma Patients. Am J Pathol. 2018;188:559\u201373.","journal-title":"Am J Pathol"},{"key":"1232_CR27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neo.2019.01.005","volume":"21","author":"M Rakaee","year":"2019","unstructured":"Rakaee M, Busund L-TR, Jamaly S, Paulsen E-E, Richardsen E, Andersen S, et al. Prognostic Value of Macrophage Phenotypes in Resectable Non\u2013Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry. Neoplasia. 2019;21:282\u201393.","journal-title":"Neoplasia"},{"key":"1232_CR28","doi-asserted-by":"crossref","unstructured":"Kazakova E, Iamshchikov P, Larionova I, Kzhyshkowska J. Macrophage scavenger receptors: Tumor support and tumor inhibition. Front Oncol. 2023;12:1096897.","DOI":"10.3389\/fonc.2022.1096897"},{"key":"1232_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03910-4","volume":"21","author":"Y Heng","year":"2023","unstructured":"Heng Y, Zhu X, Lin H, jingyu M, Ding X, Tao L, et al. CD206+ tumor-associated macrophages interact with CD4+ tumor-infiltrating lymphocytes and predict adverse patient outcome in human laryngeal squamous cell carcinoma. J Transl Med. 2023;21:167.","journal-title":"J Transl Med"},{"key":"1232_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13211","volume":"9","author":"X Wang","year":"2023","unstructured":"Wang X, Yuwen T, Zhong Y, Li Z-G, Wang X-Y. A new method for predicting the prognosis of colorectal cancer patients through a combination of multiple tumor-associated macrophage markers at the invasive front. Heliyon. 2023;9:e13211.","journal-title":"Heliyon"},{"key":"1232_CR31","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/ijc.31545","volume":"143","author":"L La Fleur","year":"2018","unstructured":"La Fleur L, Boura VF, Alexeyenko A, Berglund A, Pont\u00e9n V, Mattsson JSM, et al. Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer. Int J Cancer. 2018;143:1741\u201352.","journal-title":"Int J Cancer"},{"key":"1232_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.lungcan.2018.07.015","volume":"123","author":"Z Li","year":"2018","unstructured":"Li Z, Maeda D, Yoshida M, Umakoshi M, Nanjo H, Shiraishi K, et al. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer. Lung Cancer. 2018;123:127\u201335.","journal-title":"Lung Cancer"},{"key":"1232_CR33","doi-asserted-by":"publisher","unstructured":"Riabov V, Yin S, Song B, Avdi\u0107 A, Schledzewski K, Ovsiy I, et al. Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model. Oncotarget. 2016;7. https:\/\/doi.org\/10.18632\/oncotarget.8857.","DOI":"10.18632\/oncotarget.8857"},{"key":"1232_CR34","first-page":"4490","volume":"18","author":"R Sumitomo","year":"2019","unstructured":"Sumitomo R, Hirai T, Fujita M, Murakami H, Otake Y, Huang C. M2 tumor-associated macrophages promote tumor progression in non-small-cell lung cancer. Exp Ther Med. 2019;18:4490\u20138.","journal-title":"Exp Ther Med"},{"key":"1232_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0976-4","volume":"18","author":"C Wei","year":"2019","unstructured":"Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol Cancer. 2019;18:64.","journal-title":"Mol Cancer"},{"key":"1232_CR36","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-18-2076","volume":"25","author":"Q Feng","year":"2019","unstructured":"Feng Q, Chang W, Mao Y, He G, Zheng P, Tang W, et al. Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer. Clin Cancer Res. 2019;25:3896\u2013907.","journal-title":"Clin Cancer Res"},{"key":"1232_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28332","volume":"10","author":"M Rakina","year":"2024","unstructured":"Rakina M, Larionova I, Kzhyshkowska J. Macrophage diversity in human cancers: New insight provided by single-cell resolution and spatial context. Heliyon. 2024;10:e28332.","journal-title":"Heliyon"},{"key":"1232_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-6629-6","volume":"20","author":"Y Kono","year":"2020","unstructured":"Kono Y, Saito H, Miyauchi W, Shimizu S, Murakami Y, Shishido Y, et al. Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients. BMC Cancer. 2020;20:175.","journal-title":"BMC Cancer"},{"key":"1232_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1436922","volume":"7","author":"T Liu","year":"2018","unstructured":"Liu T, Larionova I, Litviakov N, Riabov V, Zavyalova M, Tsyganov M, et al. Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy. Oncoimmunology. 2018;7:e1436922.","journal-title":"Oncoimmunology"},{"key":"1232_CR40","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","volume":"35","author":"L Cassetta","year":"2019","unstructured":"Cassetta L, Fragkogianni S, Sims AH, Swierczak A, Forrester LM, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588\u2013602.e10.","journal-title":"Cancer Cell"},{"key":"1232_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1058337","volume":"13","author":"E Kazakova","year":"2023","unstructured":"Kazakova E, Rakina M, Sudarskikh T, Iamshchikov P, Tarasova A, Tashireva L, et al. Angiogenesis regulators S100A4, SPARC and SPP1 correlate with macrophage infiltration and are prognostic biomarkers in colon and rectal cancers. Front Oncol. 2023;13:1058337.","journal-title":"Front Oncol"},{"key":"1232_CR42","doi-asserted-by":"publisher","unstructured":"Larionova I, Kazakova E, Gerashchenko T, Kzhyshkowska J. New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis. Cancers (Basel) 2021;13. https:\/\/doi.org\/10.3390\/cancers13133253.","DOI":"10.3390\/cancers13133253"},{"key":"1232_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.891652","volume":"12","author":"TBin Emran","year":"2022","unstructured":"Emran TBin, Shahriar A, Mahmud AR, Rahman T, Abir MH, Siddiquee MF-R, et al. Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches. Front Oncol. 2022;12:891652.","journal-title":"Front Oncol"},{"key":"1232_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41417-023-00704-0","volume":"31","author":"J Wu","year":"2024","unstructured":"Wu J, Shen Y, Zeng G, Liang Y, Liao G. SPP1+ TAM subpopulations in tumor microenvironment promote intravasation and metastasis of head and neck squamous cell carcinoma. Cancer Gene Ther. 2024;31:311\u201321.","journal-title":"Cancer Gene Ther"},{"key":"1232_CR45","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","volume":"20","author":"M Bied","year":"2023","unstructured":"Bied M, Ho WW, Ginhoux F, Bl\u00e9riot C. Roles of macrophages in tumor development: a spatiotemporal perspective. Cell Mol Immunol. 2023;20:983\u201392.","journal-title":"Cell Mol Immunol"},{"key":"1232_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019;12:76.","journal-title":"J Hematol Oncol"},{"key":"1232_CR47","doi-asserted-by":"publisher","first-page":"115610","DOI":"10.1016\/j.biopha.2023.115610","volume":"167","author":"J Zhang","year":"2023","unstructured":"Zhang J, Dong Y, Di S, Xie S, Fan B, Gong T. Tumor associated macrophages in esophageal squamous carcinoma: Promising therapeutic implications. Biomedicine Pharmacother. 2023;167:115610.","journal-title":"Biomedicine Pharmacother"},{"key":"1232_CR48","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.1002\/jcb.26918","volume":"119","author":"J Zhou","year":"2018","unstructured":"Zhou J, Zheng S, Liu T, Liu Q, Chen Y, Tan D, et al. IL-1\u03b2 from M2 macrophages promotes migration and invasion of ESCC cells enhancing epithelial-mesenchymal transition and activating NF-\u03baB signaling pathway. J Cell Biochem. 2018;119:7040\u201352.","journal-title":"J Cell Biochem"},{"key":"1232_CR49","doi-asserted-by":"publisher","first-page":"e0133552","DOI":"10.1371\/journal.pone.0133552","volume":"10","author":"MM Bostr\u00f6m","year":"2015","unstructured":"Bostr\u00f6m MM, Irjala H, Mirtti T, Taimen P, Kauko T, \u00c5lgars A, et al. Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer. PLoS One. 2015;10:e0133552.","journal-title":"PLoS One"},{"key":"1232_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.657318","volume":"11","author":"H Shen","year":"2021","unstructured":"Shen H, Liu J, Chen S, Ma X, Ying Y, Li J, et al. Prognostic Value of Tumor-Associated Macrophages in Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Front Oncol. 2021;11:657318.","journal-title":"Front Oncol"},{"key":"1232_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37671-3","volume":"13","author":"A Ali","year":"2023","unstructured":"Ali A, Adams DL, Kasabwala DM, Tang C-M, Ho TH. Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time. Sci Rep. 2023;13:10544.","journal-title":"Sci Rep."},{"key":"1232_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-8-1","volume":"8","author":"EW Brenu","year":"2010","unstructured":"Brenu EW, Staines DR, Baskurt OK, Ashton KJ, Ramos SB, Christy RM, et al. Immune and hemorheological changes in Chronic Fatigue Syndrome. J Transl Med. 2010;8:1.","journal-title":"J Transl Med"},{"key":"1232_CR53","doi-asserted-by":"publisher","first-page":"e1106677","DOI":"10.1080\/2162402X.2015.1106677","volume":"5","author":"VH Koelzer","year":"2016","unstructured":"Koelzer VH, Canonica K, Dawson H, Sokol L, Karamitopoulou-Diamantis E, Lugli A, et al. Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome. Oncoimmunology. 2016;5:e1106677.","journal-title":"Oncoimmunology"},{"key":"1232_CR54","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/his.12607","volume":"66","author":"S Tiainen","year":"2015","unstructured":"Tiainen S, Tumelius R, Rilla K, H\u00e4m\u00e4l\u00e4inen K, Tammi M, Tammi R, et al. High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer. Histopathology. 2015;66:873\u201383.","journal-title":"Histopathology"},{"key":"1232_CR55","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.7150\/jca.33914","volume":"10","author":"C Ni","year":"2019","unstructured":"Ni C, Yang L, Xu Q, Yuan H, Wang W, Xia W, et al. CD68- and CD163-positive tumor infiltrating macrophages in non-metastatic breast cancer: a retrospective study and meta-analysis. J Cancer. 2019;10:4463\u201372.","journal-title":"J Cancer"},{"key":"1232_CR56","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00262-022-03173-w","volume":"71","author":"H Zhang","year":"2022","unstructured":"Zhang H, Liu Z, Wen H, Guo Y, Xu F, Zhu Q, et al. Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer. Cancer Immunol, Immunother. 2022;71:2511\u201322.","journal-title":"Cancer Immunol, Immunother"},{"key":"1232_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/srep15651","volume":"5","author":"M Lundholm","year":"2015","unstructured":"Lundholm M, H\u00e4ggl\u00f6f C, Wikberg ML, Stattin P, Egevad L, Bergh A, et al. Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions. Sci Rep. 2015;5:15651.","journal-title":"Sci Rep."},{"key":"1232_CR58","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.lungcan.2013.03.003","volume":"81","author":"A Carus","year":"2013","unstructured":"Carus A, Ladekarl M, Hager H, Pilegaard H, Nielsen PS, Donskov F. Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome. Lung Cancer. 2013;81:130\u20137.","journal-title":"Lung Cancer"},{"key":"1232_CR59","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/ijc.26457","volume":"131","author":"A Algars","year":"2012","unstructured":"Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundstr\u00f6m J, Salmi M, et al. Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int J Cancer. 2012;131:864\u201373.","journal-title":"Int J Cancer"},{"key":"1232_CR60","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1158\/2326-6066.CIR-22-0271","volume":"10","author":"M Bugatti","year":"2022","unstructured":"Bugatti M, Bergamini M, Missale F, Monti M, Ardighieri L, Pezzali I, et al. A Population of TIM4+FOLR2+ Macrophages Localized in Tertiary Lymphoid Structures Correlates to an Active Immune Infiltrate Across Several Cancer Types. Cancer Immunol Res. 2022;10:1340\u201353.","journal-title":"Cancer Immunol Res"},{"key":"1232_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.imbio.2015.09.011","volume":"222","author":"M Buldakov","year":"2017","unstructured":"Buldakov M, Zavyalova M, Krakhmal N, Telegina N, Vtorushin S, Mitrofanova I, et al. CD68+, but not stabilin-1+ tumor associated macrophages in gaps of ductal tumor structures negatively correlate with the lymphatic metastasis in human breast cancer. Immunobiology. 2017;222:31\u20138.","journal-title":"Immunobiology"},{"key":"1232_CR62","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.imbio.2016.11.012","volume":"222","author":"LA Tashireva","year":"2017","unstructured":"Tashireva LA, Denisov EV, Gerashchenko TS, Pautova DN, Buldakov MA, Zavyalova MV, et al. Intratumoral heterogeneity of macrophages and fibroblasts in breast cancer is associated with the morphological diversity of tumor cells and contributes to lymph node metastasis. Immunobiology. 2017;222:631\u201340.","journal-title":"Immunobiology"},{"key":"1232_CR63","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.7150\/jca.25155","volume":"9","author":"M Yang","year":"2018","unstructured":"Yang M, Li Z, Ren M, Li S, Zhang L, Zhang X, et al. Stromal Infiltration of Tumor-Associated Macrophages Conferring Poor Prognosis of Patients with Basal-Like Breast Carcinoma. J Cancer. 2018;9:2308\u201316.","journal-title":"J Cancer"},{"key":"1232_CR64","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","volume":"42","author":"W Wang","year":"2024","unstructured":"Wang W, Li T, Cheng Y, Li F, Qi S, Mao M, et al. Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization. Cancer Cell. 2024;42:815\u201332.e12.","journal-title":"Cancer Cell"},{"key":"1232_CR65","doi-asserted-by":"publisher","unstructured":"Sattiraju A, Kang S, Giotti B, Chen Z, Marallano V, Brusco C, et al. Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression. Immunity 2023;.56. https:\/\/doi.org\/10.1016\/J.IMMUNI.2023.06.017.","DOI":"10.1016\/J.IMMUNI.2023.06.017"},{"key":"1232_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01645-2","volume":"21","author":"R Bai","year":"2022","unstructured":"Bai R, Li Y, Jian L, Yang Y, Zhao L, Wei M. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies. Mol Cancer. 2022;21:177.","journal-title":"Mol Cancer"},{"key":"1232_CR67","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"R-Y Ma","year":"2022","unstructured":"Ma R-Y, Black A, Qian B-Z. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 2022;43:546\u201363.","journal-title":"Trends Immunol"},{"key":"1232_CR68","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1016\/j.cell.2022.10.007","volume":"185","author":"MD Park","year":"2022","unstructured":"Park MD, Silvin A, Ginhoux F, Merad M. Macrophages in health and disease. Cell. 2022;185:4259\u201379.","journal-title":"Cell"},{"key":"1232_CR69","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41576-021-00370-8","volume":"22","author":"SK Longo","year":"2021","unstructured":"Longo SK, Guo MG, Ji AL, Khavari PA. Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics. Nat Rev Genet. 2021;22:627\u201344.","journal-title":"Nat Rev Genet"},{"key":"1232_CR70","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13046-019-1259-z","volume":"38","author":"A Rotte","year":"2019","unstructured":"Rotte A. Combination of CTLA-4 and PD-1 blockers for treatment of cancer. J Exp Clin Cancer Res. 2019;38:255.","journal-title":"J Exp Clin Cancer Res"},{"key":"1232_CR71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","volume":"52","author":"PS Hegde","year":"2020","unstructured":"Hegde PS, Chen DS. Top 10 Challenges in Cancer Immunotherapy. Immunity. 2020;52:17\u201335.","journal-title":"Immunity"},{"key":"1232_CR72","doi-asserted-by":"publisher","first-page":"533888","DOI":"10.3389\/fimmu.2020.00784","volume":"11","author":"F Petitprez","year":"2020","unstructured":"Petitprez F, Meylan M, de Reyni\u00e8s A, Saut\u00e8s-Fridman C, Fridman WH. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies. Front Immunol. 2020;11:533888.","journal-title":"Front Immunol"},{"key":"1232_CR73","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-022-00866-3","volume":"29","author":"A Tiwari","year":"2022","unstructured":"Tiwari A, Trivedi R, Lin S-Y. Tumor microenvironment: barrier or opportunity towards effective cancer therapy. J Biomed Sci. 2022;29:83.","journal-title":"J Biomed Sci"},{"key":"1232_CR74","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xun Z, Ma K, Liang S, Li X, Zhou S, et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J Hepatol. 2023;78:770\u201382.","journal-title":"J Hepatol"},{"key":"1232_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z, et al. Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer. Nat Commun. 2022;13:1742.","journal-title":"Nat Commun"},{"key":"1232_CR76","doi-asserted-by":"publisher","unstructured":"Roelands J, van der Ploeg M, Ijsselsteijn M, Dang H, Boonstra J, Hardwick J, et al. Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis. Gut 2023; https:\/\/doi.org\/10.1136\/GUTJNL-2022-327608.","DOI":"10.1136\/GUTJNL-2022-327608"},{"key":"1232_CR77","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2023.2260618","volume":"12","author":"S Martinez-Morilla","year":"2023","unstructured":"Martinez-Morilla S, Moutafi M, Fernandez AI, Jessel S, Divakar P, Wong PF, et al. Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy. Oncoimmunology. 2023;12:2260618.","journal-title":"Oncoimmunology"},{"key":"1232_CR78","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2023.11.032","volume":"187","author":"D Kirschenbaum","year":"2024","unstructured":"Kirschenbaum D, Xie K, Ingelfinger F, Katzenelenbogen Y, Abadie K, Look T, et al. Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma. Cell. 2024;187:149\u201365.e23.","journal-title":"Cell"},{"key":"1232_CR79","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","volume":"23","author":"M Colonna","year":"2023","unstructured":"Colonna M. The biology of TREM receptors. Nat Rev Immunol. 2023;23:580\u201394.","journal-title":"Nat Rev Immunol"},{"key":"1232_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101739","volume":"67","author":"M Molgora","year":"2023","unstructured":"Molgora M, Liu YA, Colonna M, Cella M. TREM2: A new player in the tumor microenvironment. Semin Immunol. 2023;67:101739.","journal-title":"Semin Immunol"},{"key":"1232_CR81","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1016\/j.cell.2021.04.038","volume":"184","author":"A Obradovic","year":"2021","unstructured":"Obradovic A, Chowdhury N, Haake SM, Ager C, Wang V, Vlahos L, et al. Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. Cell. 2021;184:2988\u20133005.e16.","journal-title":"Cell"},{"key":"1232_CR82","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1158\/0008-5472.CAN-22-1427","volume":"82","author":"E Timperi","year":"2022","unstructured":"Timperi E, Gueguen P, Molgora M, Magagna I, Kieffer Y, Lopez-Lastra S, et al. Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer. Cancer Res. 2022;82:3291\u2013306.","journal-title":"Cancer Res"},{"key":"1232_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.848367","volume":"13","author":"L Zhou","year":"2022","unstructured":"Zhou L, Wang M, Guo H, Hou J, Zhang Y, Li M, et al. Integrated Analysis Highlights the Immunosuppressive Role of TREM2+ Macrophages in Hepatocellular Carcinoma. Front Immunol. 2022;13:848367.","journal-title":"Front Immunol"},{"key":"1232_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18546-x","volume":"11","author":"D Xiong","year":"2020","unstructured":"Xiong D, Wang Y, You M. A gene expression signature of TREM2hi macrophages and \u03b3\u03b4 T cells predicts immunotherapy response. Nat Commun. 2020;11:5084.","journal-title":"Nat Commun"},{"key":"1232_CR85","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","volume":"182","author":"M Molgora","year":"2020","unstructured":"Molgora M, Esaulova E, Vermi W, Hou J, Chen Y, Jingqin L, et al. TREM2 Modulation Remodels the Tumor Myeloid Landscape, Enhancing Anti-PD-1 Immunotherapy. Cell. 2020;182:886.","journal-title":"Cell"},{"key":"1232_CR86","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41416-024-02683-x","volume":"130","author":"C Wang","year":"2024","unstructured":"Wang C, Li Y, Wang L, Han Y, Gao X, Li T, et al. SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration. Br J Cancer. 2024;130:1770\u201382.","journal-title":"Br J Cancer"},{"key":"1232_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10485-8","volume":"22","author":"W Gao","year":"2022","unstructured":"Gao W, Liu D, Sun H, Shao Z, Shi P, Li T, et al. SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer. BMC Cancer. 2022;22:1367.","journal-title":"BMC Cancer"},{"key":"1232_CR88","doi-asserted-by":"publisher","unstructured":"Matsubara E, Komohara Y, Esumi S, Shinchi Y, Ishizuka S, Mito R et al. SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma. Cancers (Basel) 2022; 14. https:\/\/doi.org\/10.3390\/CANCERS14184374.","DOI":"10.3390\/CANCERS14184374"},{"key":"1232_CR89","doi-asserted-by":"publisher","unstructured":"Xie Z, Zheng G, Niu L, Du K, Li R, Dan H, et al. SPP1+ macrophages in colorectal cancer: Markers of malignancy and promising therapeutic targets. Genes Dis. 2024;101340. https:\/\/doi.org\/10.1016\/j.gendis.2024.101340","DOI":"10.1016\/j.gendis.2024.101340"},{"key":"1232_CR90","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13578-024-01218-4","volume":"14","author":"W Tang","year":"2024","unstructured":"Tang W, Lo CWS, Ma W, Chu ATW, Tong AHY, Chung BHY. Revealing the role of SPP1+ macrophages in glioma prognosis and therapeutic targeting by investigating tumor-associated macrophage landscape in grade 2 and 3 gliomas. Cell Biosci. 2024;14:37.","journal-title":"Cell Biosci"},{"key":"1232_CR91","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-024-01754-7","volume":"12","author":"F Yalcin","year":"2024","unstructured":"Yalcin F, Haneke H, Efe IE, Kuhrt LD, Motta E, Nickl B, et al. Tumor associated microglia\/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma. Acta Neuropathol Commun. 2024;12:50.","journal-title":"Acta Neuropathol Commun"},{"key":"1232_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104239","volume":"83","author":"A Xiong","year":"2022","unstructured":"Xiong A, Zhang J, Chen Y, Zhang Y, Yang F. Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM. EBioMedicine. 2022;83:104239.","journal-title":"EBioMedicine"},{"key":"1232_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49885-8","volume":"15","author":"A Coulton","year":"2024","unstructured":"Coulton A, Murai J, Qian D, Thakkar K, Lewis CE, Litchfield K. Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response. Nat Commun. 2024;15:5665.","journal-title":"Nat Commun"},{"key":"1232_CR94","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.it.2023.10.007","volume":"44","author":"I Nasir","year":"2023","unstructured":"Nasir I, McGuinness C, Poh AR, Ernst M, Darcy PK, Britt KL. Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies. Trends Immunol. 2023;44:971\u201385.","journal-title":"Trends Immunol"},{"key":"1232_CR95","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/j.celrep.2016.04.084","volume":"15","author":"A-M Georgoudaki","year":"2016","unstructured":"Georgoudaki A-M, Prokopec KE, Boura VF, Hellqvist E, Sohn S, \u00d6stling J, et al. Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis. Cell Rep. 2016;15:2000\u201311.","journal-title":"Cell Rep."},{"key":"1232_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109844","volume":"37","author":"M Binnewies","year":"2021","unstructured":"Binnewies M, Pollack JL, Rudolph J, Dash S, Abushawish M, Lee T, et al. Targeting TREM2 on tumor-associated macrophages enhances immunotherapy. Cell Rep. 2021;37:109844.","journal-title":"Cell Rep."},{"key":"1232_CR97","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1084\/jem.189.9.1497","volume":"189","author":"A Palecanda","year":"1999","unstructured":"Palecanda A, Paulauskis J, Al-Mutairi E, Imrich A, Qin G, Suzuki H, et al. Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J Exp Med. 1999;189:1497\u2013506.","journal-title":"J Exp Med"},{"key":"1232_CR98","doi-asserted-by":"publisher","unstructured":"Salter B, Zhao N, Son K, Tan NS, Dvorkin-Gheva A, Radford K, et al. Airway autoantibodies are determinants of asthma severity. Eur Respir J. 2022;60. https:\/\/doi.org\/10.1183\/13993003.00442-2022.","DOI":"10.1183\/13993003.00442-2022"},{"key":"1232_CR99","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adi5374","volume":"9","author":"B Di Luccia","year":"2024","unstructured":"Di Luccia B, Molgora M, Khantakova D, Jaeger N, Chang H-W, Czepielewski RS, et al. TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti-PD-1 tumor immunotherapy. Sci Immunol. 2024;9:eadi5374.","journal-title":"Sci Immunol"},{"key":"1232_CR100","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41590-023-01475-4","volume":"24","author":"MD Park","year":"2023","unstructured":"Park MD, Reyes-Torres I, LeBerichel J, Hamon P, LaMarche NM, Hegde S, et al. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. Nat Immunol. 2023;24:792\u2013801.","journal-title":"Nat Immunol"},{"key":"1232_CR101","doi-asserted-by":"publisher","unstructured":"Gessain G, Anzali A-A, Lerousseau M, Mulder K, Bied M, Auperin A, et al. Trem2-expressing multinucleated giant macrophages are a biomarker of good prognosis in head and neck squamous cell carcinoma. Cancer Discov. 2024. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0018.","DOI":"10.1158\/2159-8290.CD-24-0018"},{"key":"1232_CR102","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1515\/hsz-2015-0269","volume":"397","author":"J Kzhyshkowska","year":"2016","unstructured":"Kzhyshkowska J, Yin S, Liu T, Riabov V, Mitrofanova I. Role of chitinase-like proteins in cancer. Biol Chem. 2016;397:231\u201347.","journal-title":"Biol Chem"},{"key":"1232_CR103","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1097\/PAS.0000000000001797","volume":"45","author":"W Chen","year":"2021","unstructured":"Chen W, Zhao L, Agoston A, White A, Mazzola E, Boyle PJ, et al. Florid Foreign Body-type Giant Cell Response to Keratin Is Associated With Improved Overall Survival in Patients Receiving Preoperative Therapy for Esophageal Squamous Cell Carcinoma. Am J Surg Pathol. 2021;45:1648\u201360.","journal-title":"Am J Surg Pathol"},{"key":"1232_CR104","doi-asserted-by":"publisher","unstructured":"Jaitin D, Adlung L, Thaiss C, Weiner A, Li B, Descamps H, et al. Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner. Cell. 2019;178. https:\/\/doi.org\/10.1016\/J.CELL.2019.05.054.","DOI":"10.1016\/J.CELL.2019.05.054"},{"key":"1232_CR105","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and Metabolism in the Tumor Microenvironment. Cell Metab. 2019;30:36\u201350.","journal-title":"Cell Metab"},{"key":"1232_CR106","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.4251\/wjgo.v13.i12.2013","volume":"13","author":"L Lu","year":"2021","unstructured":"Lu L, Liu Y-J, Cheng P-Q, Hu D, Xu H-C, Ji G. Macrophages play a role in inflammatory transformation of colorectal cancer. World J Gastrointest Oncol. 2021;13:2013\u201328.","journal-title":"World J Gastrointest Oncol"},{"key":"1232_CR107","doi-asserted-by":"publisher","unstructured":"Gorvel L, Olive D. Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation. Semin Immunol 2023;65. https:\/\/doi.org\/10.1016\/J.SMIM.2022.101671.","DOI":"10.1016\/J.SMIM.2022.101671"},{"key":"1232_CR108","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"GBD 2019 Hepatitis B Collaborators.","year":"2022","unstructured":"GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7:796\u2013829.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1232_CR109","doi-asserted-by":"publisher","unstructured":"Huang D, Song S, Wu Z, Wu W, Cui X, Chen J, et al. Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages. Cancer Res. 2017;77. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2706.","DOI":"10.1158\/0008-5472.CAN-16-2706"},{"key":"1232_CR110","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41416-020-0872-0","volume":"123","author":"MS Gilardini Montani","year":"2020","unstructured":"Gilardini Montani MS, Falcinelli L, Santarelli R, Granato M, Romeo MA, Cecere N, et al. KSHV infection skews macrophage polarisation towards M2-like\/TAM and activates Ire1 \u03b1-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression. Br J Cancer. 2020;123:298\u2013306.","journal-title":"Br J Cancer"},{"key":"1232_CR111","doi-asserted-by":"publisher","unstructured":"Nikitina E, Larionova I, Choinzonov E, Kzhyshkowska J. Monocytes and Macrophages as Viral Targets and Reservoirs. Int J Mol Sci. 2018;19. https:\/\/doi.org\/10.3390\/IJMS19092821.","DOI":"10.3390\/IJMS19092821"},{"key":"1232_CR112","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ygyno.2006.11.023","volume":"105","author":"LS Hammes","year":"2007","unstructured":"Hammes LS, Tekmal RR, Naud P, Edelweiss MI, Kirma N, Valente PT, et al. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression\u2013clinicopathological correlation. Gynecol Oncol. 2007;105:157\u201365.","journal-title":"Gynecol Oncol"},{"key":"1232_CR113","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1158\/1078-0432.CCR-09-0489","volume":"15","author":"AP Lepique","year":"2009","unstructured":"Lepique AP, Daghastanli KRP, Cuccovia IM, Villa LL. HPV16 tumor associated macrophages suppress antitumor T cell responses. Clin Cancer Res. 2009;15:4391\u2013400.","journal-title":"Clin Cancer Res"},{"key":"1232_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1032819","volume":"13","author":"Y-Z Zhang","year":"2022","unstructured":"Zhang Y-Z, Zeb A, Cheng L-F. Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis. Front Immunol. 2022;13:1032819.","journal-title":"Front Immunol"},{"key":"1232_CR115","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1080\/15384101.2017.1356509","volume":"16","author":"N Bhaskaran","year":"2017","unstructured":"Bhaskaran N, Ghosh SK, Yu X, Qin S, Weinberg A, Pandiyan P, et al. Kaposi\u2019s sarcoma-associated herpesvirus infection promotes differentiation and polarization of monocytes into tumor-associated macrophages. Cell Cycle. 2017;16:1611\u201321.","journal-title":"Cell Cycle"},{"key":"1232_CR116","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1111\/jcmm.13847","volume":"22","author":"Y Che","year":"2018","unstructured":"Che Y, Geng B, Xu Y, Miao X, Chen L, Mu X, et al. Helicobacter pylori-induced exosomal MET educates tumour-associated macrophages to promote gastric cancer progression. J Cell Mol Med. 2018;22:5708\u201319.","journal-title":"J Cell Mol Med"},{"key":"1232_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00522-z","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, Wang J, Chen Z, Luo J, Guo W, Sun L, et al. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol. 2024;8:31.","journal-title":"NPJ Precis Oncol"},{"key":"1232_CR118","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/JLB.MR0218-056RR","volume":"106","author":"LR Sanchez","year":"2019","unstructured":"Sanchez LR, Borriello L, Entenberg D, Condeelis JS, Oktay MH, Karagiannis GS. The emerging roles of macrophages in cancer metastasis and response to chemotherapy. J Leukoc Biol. 2019;106:259\u201374.","journal-title":"J Leukoc Biol"},{"key":"1232_CR119","doi-asserted-by":"publisher","first-page":"1596004","DOI":"10.1080\/2162402X.2019.1596004","volume":"8","author":"I Larionova","year":"2019","unstructured":"Larionova I, Cherdyntseva N, Liu T, Patysheva M, Rakina M, Kzhyshkowska J. Interaction of tumor-associated macrophages and cancer chemotherapy. Oncoimmunology. 2019;8:1596004.","journal-title":"Oncoimmunology"},{"key":"1232_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110865","volume":"39","author":"M Laviron","year":"2022","unstructured":"Laviron M, Petit M, Weber-Delacroix E, Combes AJ, Arkal AR, Barth\u00e9l\u00e9my S, et al. Tumor-associated macrophage heterogeneity is driven by tissue territories in breast cancer. Cell Rep. 2022;39:110865.","journal-title":"Cell Rep."},{"key":"1232_CR121","doi-asserted-by":"publisher","unstructured":"Zhang X-M, Chen D-G, Li SC, Zhu B, Li Z-J. Embryonic Origin and Subclonal Evolution of Tumor-Associated Macrophages Imply Preventive Care for Cancer. Cells 2021;10. https:\/\/doi.org\/10.3390\/cells10040903.","DOI":"10.3390\/cells10040903"},{"key":"1232_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.788365","volume":"11","author":"T Hourani","year":"2021","unstructured":"Hourani T, Holden JA, Li W, Lenzo JC, Hadjigol S, O\u2019Brien-Simpson NM. Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting. Front Oncol. 2021;11:788365.","journal-title":"Front Oncol"},{"key":"1232_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cmi.2014.83","volume":"12","author":"Y Liu","year":"2015","unstructured":"Liu Y, Cao X. The origin and function of tumor-associated macrophages. Cell Mol Immunol. 2015;12:1\u20134.","journal-title":"Cell Mol Immunol"},{"key":"1232_CR124","doi-asserted-by":"publisher","unstructured":"Etzerodt A, Moulin M, Doktor TK, Delfini M, Mossadegh-Keller N, Bajenoff M, et al. Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer. J Exp Med 2020;217. https:\/\/doi.org\/10.1084\/jem.20191869.","DOI":"10.1084\/jem.20191869"},{"key":"1232_CR125","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s42003-023-04525-7","volume":"6","author":"R Hirano","year":"2023","unstructured":"Hirano R, Okamoto K, Shinke M, Sato M, Watanabe S, Watanabe H, et al. Tissue-resident macrophages are major tumor-associated macrophage resources, contributing to early TNBC development, recurrence, and metastases. Commun Biol. 2023;6:144.","journal-title":"Commun Biol"},{"key":"1232_CR126","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2022.02.021","volume":"185","author":"R Nalio Ramos","year":"2022","unstructured":"Nalio Ramos R, Missolo-Koussou Y, Gerber-Ferder Y, Bromley CP, Bugatti M, N\u00fa\u00f1ez NG, et al. Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer. Cell. 2022;185:1189\u20131207.e25.","journal-title":"Cell"},{"key":"1232_CR127","doi-asserted-by":"publisher","unstructured":"Caronni N, La Terza F, Vittoria F, Barbiera G, Mezzanzanica L, Cuzzola V, et al. IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer. Nature 2023;623. https:\/\/doi.org\/10.1038\/S41586-023-06685-2.","DOI":"10.1038\/S41586-023-06685-2"},{"key":"1232_CR128","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.ccell.2021.10.009","volume":"39","author":"AM Leader","year":"2021","unstructured":"Leader AM, Grout JA, Maier BB, Nabet BY, Park MD, Tabachnikova A, et al. Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification. Cancer Cell. 2021;39:1594\u2013609.e12.","journal-title":"Cancer Cell"},{"key":"1232_CR129","doi-asserted-by":"publisher","unstructured":"Casanova-Acebes M, Dalla E, Leader A, LeBerichel J, Nikolic J, Morales B, et al. Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells. Nature 2021;595. https:\/\/doi.org\/10.1038\/S41586-021-03651-8.","DOI":"10.1038\/S41586-021-03651-8"},{"key":"1232_CR130","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.immuni.2017.07.014","volume":"47","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Herndon JM, Sojka DK, Kim K-W, Knolhoff BL, Zuo C, et al. Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression. Immunity. 2017;47:323\u201338.e6.","journal-title":"Immunity"},{"key":"1232_CR131","doi-asserted-by":"publisher","unstructured":"Roy AG, Robinson JM, Sharma P, Rodriguez-Garcia A, Poussin MA, Nickerson-Nutter C, et al. Folate Receptor Beta as a Direct and Indirect Target for Antibody-Based Cancer Immunotherapy. Int J Mol Sci 2021;22. https:\/\/doi.org\/10.3390\/ijms22115572.","DOI":"10.3390\/ijms22115572"},{"key":"1232_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06021-6","volume":"14","author":"C Xiang","year":"2023","unstructured":"Xiang C, Zhang M, Shang Z, Chen S, Zhao J, Ding B, et al. Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma. Cell Death Dis. 2023;14:493.","journal-title":"Cell Death Dis"},{"key":"1232_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44886-z","volume":"15","author":"C Cohen","year":"2024","unstructured":"Cohen C, Mhaidly R, Croizer H, Kieffer Y, Leclere R, Vincent-Salomon A, et al. WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease. Nat Commun. 2024;15:743.","journal-title":"Nat Commun"},{"key":"1232_CR134","doi-asserted-by":"publisher","unstructured":"G\u00f3mez-Oro C, Latorre MC, Arribas-Poza P, Ib\u00e1\u00f1ez-Escribano A, Baca-Cornejo KR, Gallego-Valle J, et al. Progesterone promotes Cxcl2-dependent vaginal neutrophil killing by activating cervical resident macrophage-neutrophil crosstalk. JCI Insight. 2024. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.177899.","DOI":"10.1172\/JCI.INSIGHT.177899"},{"key":"1232_CR135","doi-asserted-by":"publisher","unstructured":"Henlon Y, Panir K, McIntyre I, Hogg C, Dhami P, Cuff A, et al. Single-cell analysis identifies distinct macrophage phenotypes associated with prodisease and proresolving functions in the endometriotic niche. Proc Natl Acad Sci USA. 2024; 121. https:\/\/doi.org\/10.1073\/PNAS.2405474121.","DOI":"10.1073\/PNAS.2405474121"},{"key":"1232_CR136","doi-asserted-by":"publisher","unstructured":"Bill R, Wirapati P, Messemaker M, Roh W, Zitti B, Duval F, et al. CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science. 2023;381. https:\/\/doi.org\/10.1126\/SCIENCE.ADE2292.","DOI":"10.1126\/SCIENCE.ADE2292"},{"key":"1232_CR137","doi-asserted-by":"publisher","first-page":"543125","DOI":"10.3389\/fonc.2020.01399","volume":"10","author":"M Kiss","year":"2020","unstructured":"Kiss M, Caro AA, Raes G, Laoui D. Systemic Reprogramming of Monocytes in Cancer. Front Oncol. 2020;10:543125.","journal-title":"Front Oncol"},{"key":"1232_CR138","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/cancers14030833","volume":"14","author":"A Robinson","year":"2022","unstructured":"Robinson A, Burgess M, Webb S, Louwe PA, Ouyang Z, Skola D, et al. Systemic Influences of Mammary Cancer on Monocytes in Mice. Cancers (Basel). 2022;14:833.","journal-title":"Cancers (Basel)"},{"key":"1232_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1332043","volume":"14","author":"V Chagovets","year":"2024","unstructured":"Chagovets V, Starodubtseva N, Tokareva A, Novoselova A, Patysheva M, Larionova I, et al. Specific changes in amino acid profiles in monocytes of patients with breast, lung, colorectal and ovarian cancers. Front Immunol. 2024;14:1332043.","journal-title":"Front Immunol"},{"key":"1232_CR140","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/pros.21078","volume":"70","author":"S Vuk-Pavlovi\u0107","year":"2010","unstructured":"Vuk-Pavlovi\u0107 S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X, et al. Immunosuppressive CD14+HLA-DRlow\/- monocytes in prostate cancer. Prostate. 2010;70:443\u201355.","journal-title":"Prostate"},{"key":"1232_CR141","doi-asserted-by":"crossref","unstructured":"Aleebrahim-Dehkordi E, Deravi N, Fallahi MS, Rezaei N. Mechanisms Underlying Tumor-Associated Macrophages (TAMs)-Facilitated Metastasis. In: Handbook of Cancer and Immunology. Springer International Publishing: Cham, 2023;1\u201354.","DOI":"10.1007\/978-3-030-80962-1_66-1"},{"key":"1232_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y, Yu Y, Wang X, Zhang T. Tumor-Associated Macrophages in Tumor Immunity. Front Immunol. 2020;11:583084.","journal-title":"Front Immunol"},{"key":"1232_CR143","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13578-022-00823-5","volume":"12","author":"M Li","year":"2022","unstructured":"Li M, He L, Zhu J, Zhang P, Liang S. Targeting tumor-associated macrophages for cancer treatment. Cell Biosci. 2022;12:85.","journal-title":"Cell Biosci"},{"key":"1232_CR144","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41:49\u201361.","journal-title":"Immunity"},{"key":"1232_CR145","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2217\/imt-2016-0135","volume":"9","author":"AJ Petty","year":"2017","unstructured":"Petty AJ, Yang Y. Tumor-associated macrophages: implications in cancer immunotherapy. Immunotherapy. 2017;9:289\u2013302.","journal-title":"Immunotherapy"},{"key":"1232_CR146","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019;26:78.","journal-title":"J Biomed Sci"},{"key":"1232_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04688-1","volume":"22","author":"Y Du","year":"2024","unstructured":"Du Y, Lin Y, Gan L, Wang S, Chen S, Li C, et al. Potential crosstalk between SPP1\u2009+\u2009TAMs and CD8\u2009+\u2009exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer. J Transl Med. 2024;22:158.","journal-title":"J Transl Med"},{"key":"1232_CR148","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1084\/jem.20182124","volume":"216","author":"A Etzerodt","year":"2019","unstructured":"Etzerodt A, Tsalkitzi K, Maniecki M, Damsky W, Delfini M, Baudoin E, et al. Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression. J Exp Med. 2019;216:2394\u2013411.","journal-title":"J Exp Med"},{"key":"1232_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113224","volume":"42","author":"W Zhong","year":"2023","unstructured":"Zhong W, Lu Y, Han X, Yang J, Qin Z, Zhang W, et al. Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity. Cell Rep. 2023;42:113224.","journal-title":"Cell Rep."},{"key":"1232_CR150","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545:495\u20139.","journal-title":"Nature"},{"key":"1232_CR151","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/2326-6066.CIR-23-0037","volume":"12","author":"W Yan","year":"2024","unstructured":"Yan W, Menjivar RE, Bonilla ME, Steele NG, Kemp SB, Du W, et al. Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancer. Cancer Immunol Res. 2024;12:91.","journal-title":"Cancer Immunol Res"},{"key":"1232_CR152","doi-asserted-by":"publisher","unstructured":"Strauss L, Mahmoud MAA, Weaver JD, Tijaro-Ovalle NM, Christofides A, Wang Q, et al. Targeted deletion of PD-1 in myeloid cells induces anti-tumor immunity. Sci Immunol. 2020;5. https:\/\/doi.org\/10.1126\/SCIIMMUNOL.AAY1863.","DOI":"10.1126\/SCIIMMUNOL.AAY1863"},{"key":"1232_CR153","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41590-022-01385-x","volume":"24","author":"A Christofides","year":"2023","unstructured":"Christofides A, Katopodi X-L, Cao C, Karagkouni D, Aliazis K, Yenyuwadee S, et al. SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses. Nat Immunol. 2023;24:55\u201368.","journal-title":"Nat Immunol"},{"key":"1232_CR154","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","volume":"23","author":"L Cassetta","year":"2023","unstructured":"Cassetta L, Pollard JW. A timeline of tumour-associated macrophage biology. Nat Rev Cancer. 2023;23:238\u201357.","journal-title":"Nat Rev Cancer"},{"key":"1232_CR155","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.802846","volume":"13","author":"H Hu","year":"2022","unstructured":"Hu H, Chen Y, Tan S, Wu S, Huang Y, Fu S, et al. The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment. Front Immunol. 2022;13:802846.","journal-title":"Front Immunol"},{"key":"1232_CR156","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"Z-L Liu","year":"2023","unstructured":"Liu Z-L, Chen H-H, Zheng L-L, Sun L-P, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther. 2023;8:198.","journal-title":"Signal Transduct Target Ther"},{"key":"1232_CR157","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fonc.2020.00221","volume":"10","author":"Y Haibe","year":"2020","unstructured":"Haibe Y, Kreidieh M, El Hajj H, Khalifeh I, Mukherji D, Temraz S, et al. Resistance Mechanisms to Anti-angiogenic Therapies in Cancer. Front Oncol. 2020;10:221.","journal-title":"Front Oncol"},{"key":"1232_CR158","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc2442","volume":"8","author":"G Bergers","year":"2008","unstructured":"Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 2008;8:592\u2013603.","journal-title":"Nat Rev Cancer"},{"key":"1232_CR159","doi-asserted-by":"publisher","first-page":"11238","DOI":"10.1158\/0008-5472.CAN-06-1278","volume":"66","author":"EY Lin","year":"2006","unstructured":"Lin EY, Li J-F, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 2006;66:11238\u201346.","journal-title":"Cancer Res"},{"key":"1232_CR160","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fphys.2014.00075","volume":"5","author":"V Riabov","year":"2014","unstructured":"Riabov V, Gudima A, Wang N, Mickley A, Orekhov A, Kzhyshkowska J. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol. 2014;5:75.","journal-title":"Front Physiol"},{"key":"1232_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104119","volume":"353","author":"L-Q Fu","year":"2020","unstructured":"Fu L-Q, Du W-L, Cai M-H, Yao J-Y, Zhao Y-Y, Mou X-Z. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis. Cell Immunol. 2020;353:104119.","journal-title":"Cell Immunol"},{"key":"1232_CR162","doi-asserted-by":"publisher","first-page":"e72480","DOI":"10.1371\/journal.pone.0072480","volume":"8","author":"JL Hern\u00e1ndez","year":"2013","unstructured":"Hern\u00e1ndez JL, Padilla L, Dakhel S, Coll T, Hervas R, Adan J, et al. Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody. PLoS One. 2013;8:e72480.","journal-title":"PLoS One"},{"key":"1232_CR163","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1038\/s41388-019-0748-z","volume":"38","author":"M Ishikawa","year":"2019","unstructured":"Ishikawa M, Osaki M, Yamagishi M, Onuma K, Ito H, Okada F, et al. Correlation of two distinct metastasis-associated proteins, MTA1 and S100A4, in angiogenesis for promoting tumor growth. Oncogene. 2019;38:4715\u201328.","journal-title":"Oncogene"},{"key":"1232_CR164","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/bjd.14718","volume":"175","author":"J Vegfors","year":"2016","unstructured":"Vegfors J, Ekman A-K, Stoll SW, Bivik Eding C, Enerb\u00e4ck C. Psoriasin (S100A7) promotes stress-induced angiogenesis. Br J Dermatol. 2016;175:1263\u201373.","journal-title":"Br J Dermatol"},{"key":"1232_CR165","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/248574","volume":"2012","author":"C Li","year":"2012","unstructured":"Li C, Li S, Jia C, Yang L, Song Z, Wang Y. Low concentration of S100A8\/9 promotes angiogenesis-related activity of vascular endothelial cells: bridges among inflammation, angiogenesis, and tumorigenesis? Mediators Inflamm. 2012;2012:248574.","journal-title":"Mediators Inflamm"},{"key":"1232_CR166","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1158\/0008-5472.CAN-19-1366","volume":"79","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Zhao H, Tian L, Nolley R, Diep AN, Ernst A, et al. S100A10 Is a Critical Mediator of GAS6\/AXL-Induced Angiogenesis in Renal Cell Carcinoma. Cancer Res. 2019;79:5758\u201368.","journal-title":"Cancer Res"},{"key":"1232_CR167","doi-asserted-by":"publisher","first-page":"466351","DOI":"10.3389\/fimmu.2019.02930","volume":"10","author":"J Kzhyshkowska","year":"2020","unstructured":"Kzhyshkowska J, Larionova I, Liu T. YKL-39 as a Potential New Target for Anti-Angiogenic Therapy in Cancer. Front Immunol. 2020;10:466351.","journal-title":"Front Immunol"},{"key":"1232_CR168","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/onc.2012.57","volume":"32","author":"I Psallidas","year":"2013","unstructured":"Psallidas I, Stathopoulos GT, Maniatis NA, Magkouta S, Moschos C, Karabela SP, et al. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion. Oncogene. 2013;32:528\u201335.","journal-title":"Oncogene"},{"key":"1232_CR169","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang L, Li Z, Skrzypczynska KM, Fang Q, Zhang W, O\u2019Brien SA, et al. Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer. Cell. 2020;181:442\u201359.e29.","journal-title":"Cell"},{"key":"1232_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1264774","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J, Zhu N, Su X, Gao Y, Yang R. Novel tumor-associated macrophage populations and subpopulations by single cell RNA sequencing. Front Immunol. 2023;14:1264774.","journal-title":"Front Immunol"},{"key":"1232_CR171","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/sj.bjc.6605538","volume":"102","author":"P Bhoopathi","year":"2010","unstructured":"Bhoopathi P, Chetty C, Gujrati M, Dinh DH, Rao JS, Lakka SS. The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine. Br J Cancer. 2010;102:530\u201340.","journal-title":"Br J Cancer"},{"key":"1232_CR172","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ccell.2016.05.017","volume":"30","author":"CE Lewis","year":"2016","unstructured":"Lewis CE, Harney AS, Pollard JW. The Multifaceted Role of Perivascular Macrophages in Tumors. Cancer Cell. 2016;30:18\u201325.","journal-title":"Cancer Cell"},{"key":"1232_CR173","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.1158\/1078-0432.CCR-10-0171","volume":"17","author":"M De Palma","year":"2011","unstructured":"De Palma M, Naldini L. Angiopoietin-2 TIEs up macrophages in tumor angiogenesis. Clin Cancer Res. 2011;17:5226\u201332.","journal-title":"Clin Cancer Res"},{"key":"1232_CR174","doi-asserted-by":"publisher","first-page":"e009368","DOI":"10.1136\/jitc-2024-009368","volume":"12","author":"H Al-janabi","year":"2024","unstructured":"Al-janabi H, Moyes K, Allen R, Fisher M, Crespo M, Gurel B, et al. Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy. J Immunother Cancer. 2024;12:e009368.","journal-title":"J Immunother Cancer"},{"key":"1232_CR175","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg9518","volume":"7","author":"JW Opzoomer","year":"2021","unstructured":"Opzoomer JW, Anstee JE, Dean I, Hill EJ, Bouybayoune I, Caron J, et al. Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression. Sci Adv. 2021;7:eabg9518.","journal-title":"Sci Adv"},{"key":"1232_CR176","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.devcel.2023.06.006","volume":"58","author":"JE Anstee","year":"2023","unstructured":"Anstee JE, Feehan KT, Opzoomer JW, Dean I, Muller HP, Bahri M, et al. LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer. Dev Cell. 2023;58:1548\u201361.e10.","journal-title":"Dev Cell"},{"key":"1232_CR177","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.celrep.2018.04.007","volume":"23","author":"EN Arwert","year":"2018","unstructured":"Arwert EN, Harney AS, Entenberg D, Wang Y, Sahai E, Pollard JW, et al. A Unidirectional Transition from Migratory to Perivascular Macrophage Is Required for Tumor Cell Intravasation. Cell Rep. 2018;23:1239\u201348.","journal-title":"Cell Rep."},{"key":"1232_CR178","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/j.immuni.2023.10.010","volume":"56","author":"MH Do","year":"2023","unstructured":"Do MH, Shi W, Ji L, Ladewig E, Zhang X, Srivastava RM, et al. Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis. Immunity. 2023;56:2555\u201369.e5.","journal-title":"Immunity"},{"key":"1232_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113507","volume":"42","author":"K Banerjee","year":"2023","unstructured":"Banerjee K, Kerzel T, Bekkhus T, de Souza Ferreira S, Wallmann T, Wallerius M, et al. VEGF-C-expressing TAMs rewire the metastatic fate of breast cancer cells. Cell Rep. 2023;42:113507.","journal-title":"Cell Rep."},{"key":"1232_CR180","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47438-4","volume":"9","author":"HR Cho","year":"2019","unstructured":"Cho HR, Kumari N, Thi Vu H, Kim H, Park C-K, Choi SH. Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI. Sci Rep. 2019;9:11085.","journal-title":"Sci Rep."},{"key":"1232_CR181","doi-asserted-by":"publisher","first-page":"e1408745","DOI":"10.1080\/2162402X.2017.1408745","volume":"7","author":"Y-M Meng","year":"2018","unstructured":"Meng Y-M, Liang J, Wu C, Xu J, Zeng D-N, Yu X-J, et al. Monocytes\/Macrophages promote vascular CXCR4 expression via the ERK pathway in hepatocellular carcinoma. Oncoimmunology. 2018;7:e1408745.","journal-title":"Oncoimmunology"},{"key":"1232_CR182","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5:28.","journal-title":"Signal Transduct Target Ther"},{"key":"1232_CR183","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis. Cell. 2023;186:1564\u201379.","journal-title":"Cell"},{"key":"1232_CR184","doi-asserted-by":"publisher","first-page":"vii89","DOI":"10.1093\/annonc\/mdq292","volume":"21","author":"P Savagner","year":"2010","unstructured":"Savagner P. The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol. 2010;21:vii89\u201392.","journal-title":"Ann Oncol"},{"key":"1232_CR185","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mrrev.2011.05.002","volume":"728","author":"F van Zijl","year":"2011","unstructured":"van Zijl F, Krupitza G, Mikulits W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res. 2011;728:23\u201334.","journal-title":"Mutat Res"},{"key":"1232_CR186","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3892\/ijo.2014.2761","volume":"46","author":"X-T Fu","year":"2015","unstructured":"Fu X-T, Dai Z, Song K, Zhang Z-J, Zhou Z-J, Zhou S-L, et al. Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2\/STAT3\/Snail pathway. Int J Oncol. 2015;46:587\u201396.","journal-title":"Int J Oncol"},{"key":"1232_CR187","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/1878-0261.12095","volume":"11","author":"M Suarez-Carmona","year":"2017","unstructured":"Suarez-Carmona M, Lesage J, Cataldo D, Gilles C. EMT and inflammation: inseparable actors of cancer progression. Mol Oncol. 2017;11:805\u201323.","journal-title":"Mol Oncol"},{"key":"1232_CR188","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01744-8","volume":"22","author":"Z Yuan","year":"2023","unstructured":"Yuan Z, Li Y, Zhang S, Wang X, Dou H, Yu X, et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol Cancer. 2023;22:48.","journal-title":"Mol Cancer"},{"key":"1232_CR189","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-0041-1733876","volume":"42","author":"DA Patten","year":"2022","unstructured":"Patten DA, Wilkinson AL, O\u2019Keeffe A, Shetty S. Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer. Semin Liver Dis. 2022;42:61\u201376.","journal-title":"Semin Liver Dis"},{"key":"1232_CR190","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1182\/blood-2005-07-2843","volume":"107","author":"J Kzhyshkowska","year":"2006","unstructured":"Kzhyshkowska J, Mamidi S, Gratchev A, Kremmer E, Schmuttermaier C, Krusell L, et al. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood. 2006;107:3221\u20138.","journal-title":"Blood"},{"key":"1232_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1000497","volume":"14","author":"I Larionova","year":"2023","unstructured":"Larionova I, Kiselev A, Kazakova E, Liu T, Patysheva M, Iamshchikov P, et al. Tumor-associated macrophages respond to chemotherapy by detrimental transcriptional reprogramming and suppressing stabilin-1 mediated clearance of EGF. Front Immunol. 2023;14:1000497.","journal-title":"Front Immunol"},{"key":"1232_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112862","volume":"408","author":"Q Xing","year":"2021","unstructured":"Xing Q, Feng Y, Sun H, Yang S, Sun T, Guo X, et al. Scavenger receptor MARCO contributes to macrophage phagocytosis and clearance of tumor cells. Exp Cell Res. 2021;408:112862.","journal-title":"Exp Cell Res"},{"key":"1232_CR193","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1038\/s44318-024-00103-7","volume":"43","author":"R Parikh","year":"2024","unstructured":"Parikh R, Parikh S, Berzin D, Vaknine H, Ovadia S, Likonen D, et al. Recycled melanoma-secreted melanosomes regulate tumor-associated macrophage diversification. EMBO J. 2024;43:3553\u201386.","journal-title":"EMBO J"},{"key":"1232_CR194","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41590-021-00921-5","volume":"22","author":"FM Consonni","year":"2021","unstructured":"Consonni FM, Bleve A, Totaro MG, Storto M, Kunderfranco P, Termanini A, et al. Heme catabolism by tumor-associated macrophages controls metastasis formation. Nat Immunol. 2021;22:595\u2013606.","journal-title":"Nat Immunol"},{"key":"1232_CR195","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.654877","volume":"12","author":"S Asiry","year":"2021","unstructured":"Asiry S, Kim G, Filippou PS, Sanchez LR, Entenberg D, Marks DK, et al. The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy. Front Immunol. 2021;12:654877.","journal-title":"Front Immunol"},{"key":"1232_CR196","doi-asserted-by":"publisher","unstructured":"Ginter PS, Karagiannis GS, Entenberg D, Lin Y, Condeelis J, Jones JG, et al. Tumor Microenvironment of Metastasis (TMEM) Doorways Are Restricted to the Blood Vessel Endothelium in Both Primary Breast Cancers and Their Lymph Node Metastases. Cancers (Basel) 2019;11. https:\/\/doi.org\/10.3390\/cancers11101507.","DOI":"10.3390\/cancers11101507"},{"key":"1232_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-017-0043-5","volume":"3","author":"JA Sparano","year":"2017","unstructured":"Sparano JA, Gray R, Oktay MH, Entenberg D, Rohan T, Xue X, et al. A metastasis biomarker (MetaSite BreastTM Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer. npj Breast Cancer 2017;3:1\u20138.","journal-title":"npj Breast Cancer"},{"key":"1232_CR198","doi-asserted-by":"publisher","unstructured":"Rohan TE, Xue X, Lin H-M, D\u2019Alfonso TM, Ginter PS, Oktay MH, et al. Tumor Microenvironment of Metastasis and Risk of Distant Metastasis of Breast Cancer. JNCI: Journal of the National Cancer Institute 2014;106. https:\/\/doi.org\/10.1093\/jnci\/dju136.","DOI":"10.1093\/jnci\/dju136"},{"key":"1232_CR199","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1158\/0008-5472.CAN-14-3587","volume":"75","author":"R Hughes","year":"2015","unstructured":"Hughes R, Qian B-Z, Rowan C, Muthana M, Keklikoglou I, Olson OC, et al. Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy. Cancer Res. 2015;75:3479\u201391.","journal-title":"Cancer Res"},{"key":"1232_CR200","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","volume":"6","author":"D Lin","year":"2021","unstructured":"Lin D, Shen L, Luo M, Zhang K, Li J, Yang Q, et al. Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther. 2021;6:404.","journal-title":"Signal Transduct Target Ther"},{"key":"1232_CR201","doi-asserted-by":"publisher","unstructured":"Manjunath Y, Porciani D, Mitchem JB, Suvilesh KN, Avella DM, Kimchi ET, et al. Tumor-Cell-Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer. Int J Mol Sci 2020;21. https:\/\/doi.org\/10.3390\/ijms21051872.","DOI":"10.3390\/ijms21051872"},{"key":"1232_CR202","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.814714","volume":"10","author":"MS Tretyakova","year":"2022","unstructured":"Tretyakova MS, Subbalakshmi AR, Menyailo ME, Jolly MK, Denisov EV. Tumor Hybrid Cells: Nature and Biological Significance. Front Cell Dev Biol. 2022;10:814714.","journal-title":"Front Cell Dev Biol"},{"key":"1232_CR203","doi-asserted-by":"publisher","first-page":"418","DOI":"10.21037\/tlcr.2017.07.04","volume":"6","author":"G Hamilton","year":"2017","unstructured":"Hamilton G, Rath B. Circulating tumor cell interactions with macrophages: implications for biology and treatment. Transl Lung Cancer Res. 2017;6:418\u201330.","journal-title":"Transl Lung Cancer Res"},{"key":"1232_CR204","doi-asserted-by":"publisher","unstructured":"Clawson G, Matters G, Xin P, Imamura-Kawasawa Y, Du Z, Thiboutot D, et al. Macrophage-tumor cell fusions from peripheral blood of melanoma patients. PLoS One 2015;10. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0134320.","DOI":"10.1371\/JOURNAL.PONE.0134320"},{"key":"1232_CR205","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.7150\/thno.82700","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Li M, Su K, Zong S, Zhang H, Xiong L. Pre-metastatic niche: from revealing the molecular and cellular mechanisms to the clinical applications in breast cancer metastasis. Theranostics. 2023;13:2301\u201318.","journal-title":"Theranostics"},{"key":"1232_CR206","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1038\/onc.2017.118","volume":"36","author":"XW Chen","year":"2017","unstructured":"Chen XW, Yu TJ, Zhang J, Li Y, Chen HL, Yang GF, et al. CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis. Oncogene. 2017;36:5045\u201357.","journal-title":"Oncogene"},{"key":"1232_CR207","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","volume":"41","author":"L Patras","year":"2023","unstructured":"Patras L, Shaashua L, Matei I, Lyden D. Immune determinants of the pre-metastatic niche. Cancer Cell. 2023;41:546\u201372.","journal-title":"Cancer Cell"},{"key":"1232_CR208","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.trecan.2018.03.011","volume":"4","author":"GR Doak","year":"2018","unstructured":"Doak GR, Schwertfeger KL, Wood DK. Distant Relations: Macrophage Functions in the Metastatic Niche. Trends Cancer. 2018;4:445\u201359.","journal-title":"Trends Cancer"},{"key":"1232_CR209","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","volume":"33","author":"SM Morrissey","year":"2021","unstructured":"Morrissey SM, Zhang F, Ding C, Montoya-Durango DE, Hu X, Yang C, et al. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 2021;33:2040\u201358.e10.","journal-title":"Cell Metab"},{"key":"1232_CR210","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17:816\u201326.","journal-title":"Nat Cell Biol"},{"key":"1232_CR211","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/hep.32009","volume":"74","author":"H Sun","year":"2021","unstructured":"Sun H, Meng Q, Shi C, Yang H, Li X, Wu S, et al. Hypoxia\u2010Inducible Exosomes Facilitate Liver\u2010Tropic Premetastatic Niche in Colorectal Cancer. Hepatology. 2021;74:2633\u201351.","journal-title":"Hepatology"},{"key":"1232_CR212","doi-asserted-by":"publisher","first-page":"29087","DOI":"10.1074\/jbc.M109.035899","volume":"284","author":"X Lu","year":"2009","unstructured":"Lu X, Kang Y. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem. 2009;284:29087\u201396.","journal-title":"J Biol Chem"},{"key":"1232_CR213","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"B-Z Qian","year":"2011","unstructured":"Qian B-Z, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475:222\u20135.","journal-title":"Nature"},{"key":"1232_CR214","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s43018-022-00353-6","volume":"3","author":"T Hongu","year":"2022","unstructured":"Hongu T, Pein M, Insua-Rodr\u00edguez J, Gutjahr E, Mattavelli G, Meier J, et al. Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs. Nat Cancer. 2022;3:486\u2013504.","journal-title":"Nat Cancer"},{"key":"1232_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215667","volume":"537","author":"C Shang","year":"2022","unstructured":"Shang C, Sun Y, Wang Y, Shi H, Han X, Mo Y, et al. CXCL10 conditions alveolar macrophages within the premetastatic niche to promote metastasis. Cancer Lett. 2022;537:215667.","journal-title":"Cancer Lett"},{"key":"1232_CR216","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1182\/blood-2011-08-376426","volume":"119","author":"AM Gil-Bernab\u00e9","year":"2012","unstructured":"Gil-Bernab\u00e9 AM, Ferjan\u010di\u010d \u0160, Tlalka M, Zhao L, Allen PD, Im JH, et al. Recruitment of monocytes\/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood. 2012;119:3164\u201375.","journal-title":"Blood"},{"key":"1232_CR217","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1089\/ars.2016.6695","volume":"25","author":"MA Hoeksema","year":"2016","unstructured":"Hoeksema MA, de Winther MPJ. Epigenetic Regulation of Monocyte and Macrophage Function. Antioxid Redox Signal. 2016;25:758\u201374.","journal-title":"Antioxid Redox Signal"},{"key":"1232_CR218","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1080\/15592294.2019.1638700","volume":"14","author":"N Jain","year":"2019","unstructured":"Jain N, Shahal T, Gabrieli T, Gilat N, Torchinsky D, Michaeli Y, et al. Global modulation in DNA epigenetics during pro-inflammatory macrophage activation. Epigenetics. 2019;14:1183\u201393.","journal-title":"Epigenetics"},{"key":"1232_CR219","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/jleuko\/qiae001","volume":"115","author":"MA Oliver","year":"2024","unstructured":"Oliver MA, Davis XD, Bohannon JK. TGF\u03b2 macrophage reprogramming: a new dimension of macrophage plasticity. J Leukoc Biol. 2024;115:411\u20134.","journal-title":"J Leukoc Biol"},{"key":"1232_CR220","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.gendis.2021.06.007","volume":"9","author":"X He","year":"2022","unstructured":"He X, Tan S, Shao Z, Wang X. Latitudinal and longitudinal regulation of tissue macrophages in inflammatory diseases. Genes Dis. 2022;9:1194\u2013207.","journal-title":"Genes Dis"},{"key":"1232_CR221","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.it.2012.11.001","volume":"34","author":"LB Ivashkiv","year":"2013","unstructured":"Ivashkiv LB. Epigenetic regulation of macrophage polarization and function. Trends Immunol. 2013;34:216\u201323.","journal-title":"Trends Immunol"},{"key":"1232_CR222","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13072-019-0279-4","volume":"12","author":"KF Dekkers","year":"2019","unstructured":"Dekkers KF, Neele AE, Jukema JW, Heijmans BT, de Winther MPJ. Human monocyte-to-macrophage differentiation involves highly localized gain and loss of DNA methylation at transcription factor binding sites. Epigenetics Chromatin. 2019;12:34.","journal-title":"Epigenetics Chromatin"},{"key":"1232_CR223","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature14192","volume":"517","author":"D Sch\u00fcbeler","year":"2015","unstructured":"Sch\u00fcbeler D. Function and information content of DNA methylation. Nature. 2015;517:321\u20136.","journal-title":"Nature"},{"key":"1232_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108640","volume":"258","author":"AV Lee","year":"2024","unstructured":"Lee AV, Nestler KA, Chiappinelli KB. Therapeutic targeting of DNA methylation alterations in cancer. Pharm Ther. 2024;258:108640.","journal-title":"Pharm Ther"},{"key":"1232_CR225","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/ijc.34364","volume":"152","author":"J Hey","year":"2023","unstructured":"Hey J, Halperin C, Hartmann M, Mayer S, Sch\u00f6nung M, Lipka DB, et al. DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple-negative breast cancer patients. Int J Cancer. 2023;152:1226\u201342.","journal-title":"Int J Cancer"},{"key":"1232_CR226","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1338244","volume":"14","author":"F Ye","year":"2024","unstructured":"Ye F, Wang L, Li Y, Dong C, Zhou L, Xu J. IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy. Front Immunol. 2024;14:1338244.","journal-title":"Front Immunol"},{"key":"1232_CR227","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1158\/0008-5472.CAN-15-2011","volume":"75","author":"NC D\u2019Amato","year":"2015","unstructured":"D\u2019Amato NC, Rogers TJ, Gordon MA, Greene LI, Cochrane DR, Spoelstra NS, et al. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer. Cancer Res. 2015;75:4651\u201364.","journal-title":"Cancer Res"},{"key":"1232_CR228","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","volume":"182","author":"A Sadik","year":"2020","unstructured":"Sadik A, Somarribas Patterson LF, \u00d6zt\u00fcrk S, Mohapatra SR, Panitz V, Secker PF, et al. IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression. Cell. 2020;182:1252\u201370.e34.","journal-title":"Cell"},{"key":"1232_CR229","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33285-x","volume":"13","author":"D Shi","year":"2022","unstructured":"Shi D, Wu X, Jian Y, Wang J, Huang C, Mo S, et al. USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer. Nat Commun. 2022;13:5644.","journal-title":"Nat Commun"},{"key":"1232_CR230","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","volume":"54","author":"K Mulder","year":"2021","unstructured":"Mulder K, Patel AA, Kong WT, Piot C, Halitzki E, Dunsmore G, et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity. 2021;54:1883\u20131900.e5.","journal-title":"Immunity"},{"key":"1232_CR231","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/nsmb1307","volume":"14","author":"JA Latham","year":"2007","unstructured":"Latham JA, Dent SYR. Cross-regulation of histone modifications. Nat Struct Mol Biol. 2007;14:1017\u201324.","journal-title":"Nat Struct Mol Biol"},{"key":"1232_CR232","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nsmb1338","volume":"14","author":"SD Taverna","year":"2007","unstructured":"Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol. 2007;14:1025\u201340.","journal-title":"Nat Struct Mol Biol"},{"key":"1232_CR233","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1126\/science.1256271","volume":"345","author":"D Lara-Astiaso","year":"2014","unstructured":"Lara-Astiaso D, Weiner A, Lorenzo-Vivas E, Zaretsky I, Jaitin DA, David E, et al. Immunogenetics. Chromatin state dynamics during blood formation. Science. 2014;345:943\u20139.","journal-title":"Science"},{"key":"1232_CR234","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature25022","volume":"553","author":"E Laurenti","year":"2018","unstructured":"Laurenti E, G\u00f6ttgens B. From haematopoietic stem cells to complex differentiation landscapes. Nature. 2018;553:418\u201326.","journal-title":"Nature"},{"key":"1232_CR235","doi-asserted-by":"publisher","DOI":"10.1126\/science.1250684","volume":"345","author":"S-C Cheng","year":"2014","unstructured":"Cheng S-C, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al. mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014;345:1250684.","journal-title":"Science"},{"key":"1232_CR236","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1161\/ATVBAHA.118.312135","volume":"39","author":"FM Davis","year":"2019","unstructured":"Davis FM, Gallagher KA. Epigenetic Mechanisms in Monocytes\/Macrophages Regulate Inflammation in Cardiometabolic and Vascular Disease. Arterioscler Thromb Vasc Biol. 2019;39:623\u201334.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1232_CR237","doi-asserted-by":"publisher","unstructured":"Van den Bossche J, Neele A, Hoeksema M, de Winther M. Macrophage polarization: the epigenetic point of view. Curr Opin Lipidol. 2014;25. https:\/\/doi.org\/10.1097\/MOL.0000000000000109.","DOI":"10.1097\/MOL.0000000000000109"},{"key":"1232_CR238","doi-asserted-by":"publisher","first-page":"514665","DOI":"10.3389\/fimmu.2020.01071","volume":"11","author":"DM Mossel","year":"2020","unstructured":"Mossel DM, Moganti K, Riabov V, Weiss C, Kopf S, Cordero J, et al. Epigenetic Regulation of S100A9 and S100A12 Expression in Monocyte-Macrophage System in Hyperglycemic Conditions. Front Immunol. 2020;11:514665.","journal-title":"Front Immunol"},{"key":"1232_CR239","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1182\/blood-2009-04-217620","volume":"114","author":"M Ishii","year":"2009","unstructured":"Ishii M, Wen H, Corsa CAS, Liu T, Coelho AL, Allen RM, et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood. 2009;114:3244\u201354.","journal-title":"Blood"},{"key":"1232_CR240","doi-asserted-by":"publisher","unstructured":"Chen S, Lu K, Hou Y, You Z, Shu C, Wei X, et al. YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6. J Immunother Cancer 2023;11. https:\/\/doi.org\/10.1136\/jitc-2022-006020.","DOI":"10.1136\/jitc-2022-006020"},{"key":"1232_CR241","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-22-1270","volume":"83","author":"X Zheng","year":"2023","unstructured":"Zheng X, Sarode P, Weigert A, Turkowski K, Chelladurai P, G\u00fcnther S, et al. The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization. Cancer Res. 2023;83:2345\u201357.","journal-title":"Cancer Res"},{"key":"1232_CR242","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41392-023-01647-6","volume":"8","author":"Z-Q Wang","year":"2023","unstructured":"Wang Z-Q, Zhang Z-C, Wu Y-Y, Pi Y-N, Lou S-H, Liu T-B, et al. Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy. Signal Transduct Target Ther. 2023;8:420.","journal-title":"Signal Transduct Target Ther"},{"key":"1232_CR243","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/path.4832","volume":"241","author":"M Liu","year":"2017","unstructured":"Liu M, Zhou J, Chen Z, Cheng AS-L. Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy. J Pathol. 2017;241:10\u201324.","journal-title":"J Pathol"},{"key":"1232_CR244","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nature09589","volume":"468","author":"E Nicodeme","year":"2010","unstructured":"Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung C, et al. Suppression of inflammation by a synthetic histone mimic. Nature. 2010;468:1119\u201323.","journal-title":"Nature"},{"key":"1232_CR245","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.4049\/jimmunol.1202838","volume":"190","author":"AC Belkina","year":"2013","unstructured":"Belkina AC, Nikolajczyk BS, Denis GV. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J Immunol. 2013;190:3670\u20138.","journal-title":"J Immunol"},{"key":"1232_CR246","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.bbrc.2017.12.103","volume":"495","author":"A Yan","year":"2018","unstructured":"Yan A, Yue T, Li L, Li W, Li Q, Li J. Bromodomain-containing protein 7 deficiency augments atherosclerotic lesions in ApoE-\/- mice. Biochem Biophys Res Commun. 2018;495:2202\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1232_CR247","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.it.2019.12.002","volume":"41","author":"J Gatchalian","year":"2020","unstructured":"Gatchalian J, Liao J, Maxwell MB, Hargreaves DC. Control of Stimulus-Dependent Responses in Macrophages by SWI\/SNF Chromatin Remodeling Complexes. Trends Immunol. 2020;41:126\u201340.","journal-title":"Trends Immunol"},{"key":"1232_CR248","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1182\/blood-2012-04-427047","volume":"120","author":"V Krasteva","year":"2012","unstructured":"Krasteva V, Buscarlet M, Diaz-Tellez A, Bernard M-A, Crabtree GR, Lessard JA. The BAF53a subunit of SWI\/SNF-like BAF complexes is essential for hemopoietic stem cell function. Blood. 2012;120:4720\u201332.","journal-title":"Blood"},{"key":"1232_CR249","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.exphem.2016.11.008","volume":"48","author":"V Krasteva","year":"2017","unstructured":"Krasteva V, Crabtree GR, Lessard JA. The BAF45a\/PHF10 subunit of SWI\/SNF-like chromatin remodeling complexes is essential for hematopoietic stem cell maintenance. Exp Hematol. 2017;48:58\u201371.e15.","journal-title":"Exp Hematol"},{"key":"1232_CR250","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15290-0","volume":"11","author":"M Yin","year":"2020","unstructured":"Yin M, Guo Y, Hu R, Cai WL, Li Y, Pei S, et al. Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction. Nat Commun. 2020;11:1833.","journal-title":"Nat Commun"},{"key":"1232_CR251","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu N-Q, Szabo AL, Chu T, Rhebergen AM, Jairam V, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513:559\u201363.","journal-title":"Nature"},{"key":"1232_CR252","doi-asserted-by":"publisher","unstructured":"Ning W-R, Jiang D, Liu X-C, Huang Y-F, Peng Z-P, Jiang Z-Z, et al. Carbonic anhydrase XII mediates the survival and prometastatic functions of macrophages in human hepatocellular carcinoma. J Clin Invest. 2022;132. https:\/\/doi.org\/10.1172\/JCI153110.","DOI":"10.1172\/JCI153110"},{"key":"1232_CR253","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"1232_CR254","doi-asserted-by":"publisher","unstructured":"Sun J, Feng Q, He Y, Wang M, Wu Y. Lactate activates CCL18 expression via H3K18 lactylation in macrophages to promote tumorigenesis of ovarian cancer. Acta Biochim Biophys Sin (Shanghai) 2024. https:\/\/doi.org\/10.3724\/abbs.2024111.","DOI":"10.3724\/abbs.2024111"},{"key":"1232_CR255","doi-asserted-by":"publisher","unstructured":"Zhang C, Zhou L, Zhang M, Du Y, Li C, Ren H. et al. H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer. Cancer Res 2024. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-3513.","DOI":"10.1158\/0008-5472.CAN-23-3513"},{"key":"1232_CR256","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4149\/neo_2024_240127N41","volume":"71","author":"J Chao","year":"2024","unstructured":"Chao J, Chen G, Huang S-T, Gu H, Liu Y-Y, Luo Y, et al. High histone H3K18 lactylation level is correlated with poor prognosis in epithelial ovarian cancer. Neoplasma. 2024;71:319\u201332.","journal-title":"Neoplasma"},{"key":"1232_CR257","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.yexcr.2019.02.021","volume":"377","author":"W Ge","year":"2019","unstructured":"Ge W, Yue Y, Xiong S. POM121 inhibits the macrophage inflammatory response by impacting NF-\u03baB P65 nuclear accumulation. Exp Cell Res. 2019;377:17\u201323.","journal-title":"Exp Cell Res"},{"key":"1232_CR258","doi-asserted-by":"publisher","unstructured":"Ju J, Zhang H, Lin M, Yan Z, An L, Cao Z, et al. The alanyl-tRNA synthetase AARS1 moonlights as a lactyl-transferase to promote YAP signaling in gastric cancer. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI174587.","DOI":"10.1172\/JCI174587"},{"key":"1232_CR259","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/JPER.23-0241","volume":"95","author":"X Liu","year":"2024","unstructured":"Liu X, Wang J, Lao M, Liu F, Zhu H, Man K, et al. Study on the effect of protein lysine lactylation modification in macrophages on inhibiting periodontitis in rats. J Periodontol. 2024;95:50\u201363.","journal-title":"J Periodontol"},{"key":"1232_CR260","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314128121","volume":"121","author":"B Xie","year":"2024","unstructured":"Xie B, Zhang M, Li J, Cui J, Zhang P, Liu F, et al. KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis. Proc Natl Acad Sci USA. 2024;121:e2314128121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1232_CR261","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1158\/1078-0432.CCR-22-3350","volume":"29","author":"K Chaudagar","year":"2023","unstructured":"Chaudagar K, Hieromnimon HM, Khurana R, Labadie B, Hirz T, Mei S, et al. Reversal of Lactate and PD-1\u2013mediated Macrophage Immunosuppression Controls Growth of PTEN\/p53-deficient Prostate Cancer. Clin Cancer Res. 2023;29:1952\u201368.","journal-title":"Clin Cancer Res"},{"key":"1232_CR262","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1158\/1078-0432.CCR-23-1441","volume":"29","author":"K Chaudagar","year":"2023","unstructured":"Chaudagar K, Hieromnimon HM, Kelley A, Labadie B, Shafran J, Rameshbabu S, et al. Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN\/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis. Clin Cancer Res. 2023;29:4930\u201340.","journal-title":"Clin Cancer Res"},{"key":"1232_CR263","first-page":"1","volume":"10","author":"T Yu","year":"2019","unstructured":"Yu T, Gan S, Zhu Q, Dai D, Li N, Wang H, et al. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24. Nat Commun 2019 10:1. 2019;10:1\u201315.","journal-title":"Nat Commun 2019 10:1"},{"key":"1232_CR264","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1016\/j.celrep.2016.08.035","volume":"16","author":"D Yan","year":"2016","unstructured":"Yan D, Wang H-W, Bowman RL, Joyce JA. STAT3 and STAT6 Signaling Pathways Synergize to Promote Cathepsin Secretion from Macrophages via IRE1\u03b1 Activation. Cell Rep. 2016;16:2914\u201327.","journal-title":"Cell Rep."},{"key":"1232_CR265","doi-asserted-by":"publisher","first-page":"78726","DOI":"10.18632\/oncotarget.12807","volume":"7","author":"W Chen","year":"2016","unstructured":"Chen W, Xu Y, Zhong J, Wang H, Weng M, Cheng Q, et al. MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway. Oncotarget. 2016;7:78726\u201335.","journal-title":"Oncotarget"},{"key":"1232_CR266","doi-asserted-by":"publisher","first-page":"e0136654","DOI":"10.1371\/journal.pone.0136654","volume":"10","author":"M Petrillo","year":"2015","unstructured":"Petrillo M, Zannoni GF, Martinelli E, Pedone Anchora L, Ferrandina G, Tropeano G, et al. Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. PLoS One. 2015;10:e0136654.","journal-title":"PLoS One"},{"key":"1232_CR267","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.imlet.2018.02.009","volume":"196","author":"R Sol\u00eds-Mart\u00ednez","year":"2018","unstructured":"Sol\u00eds-Mart\u00ednez R, Cancino-Marentes M, Hern\u00e1ndez-Flores G, Ortiz-Lazareno P, Mandujano-\u00c1lvarez G, Cruz-G\u00e1lvez C, et al. Regulation of immunophenotype modulation of monocytes-macrophages from M1 into M2 by prostate cancer cell-culture supernatant via transcription factor STAT3. Immunol Lett. 2018;196:140\u20138.","journal-title":"Immunol Lett"},{"key":"1232_CR268","doi-asserted-by":"publisher","first-page":"9419","DOI":"10.1002\/jcb.27259","volume":"119","author":"Z Yin","year":"2018","unstructured":"Yin Z, Ma T, Lin Y, Lu X, Zhang C, Chen S, et al. IL-6\/STAT3 pathway intermediates M1\/M2 macrophage polarization during the development of hepatocellular carcinoma. J Cell Biochem. 2018;119:9419\u201332.","journal-title":"J Cell Biochem"},{"key":"1232_CR269","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1172\/JCI35213","volume":"118","author":"M Kujawski","year":"2008","unstructured":"Kujawski M, Kortylewski M, Lee H, Herrmann A, Kay H, Yu H. Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J Clin Invest. 2008;118:3367\u201377.","journal-title":"J Clin Invest"},{"key":"1232_CR270","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06268-0","volume":"9","author":"C-C Lee","year":"2018","unstructured":"Lee C-C, Lin J-C, Hwang W-L, Kuo Y-J, Chen H-K, Tai S-K, et al. Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization. Nat Commun. 2018;9:3763.","journal-title":"Nat Commun"},{"key":"1232_CR271","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, et al. Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;82:1660\u201377.e10.","journal-title":"Mol Cell"},{"key":"1232_CR272","doi-asserted-by":"publisher","unstructured":"Verdeil G, Lawrence T, Schmitt-Verhulst A-M, Auphan-Anezin N. Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy. Cancers (Basel) 2019;11. https:\/\/doi.org\/10.3390\/cancers11121832.","DOI":"10.3390\/cancers11121832"},{"key":"1232_CR273","doi-asserted-by":"publisher","first-page":"405349","DOI":"10.3389\/fendo.2018.00471","volume":"9","author":"C Giuliani","year":"2018","unstructured":"Giuliani C, Bucci I, Napolitano G. The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer. Front Endocrinol (Lausanne). 2018;9:405349.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1232_CR274","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13:460\u20139.","journal-title":"Trends Mol Med"},{"key":"1232_CR275","doi-asserted-by":"publisher","first-page":"112681","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T. Toll-Like Receptor Signaling Pathways. Front Immunol. 2014;5:112681.","journal-title":"Front Immunol"},{"key":"1232_CR276","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3332\/ecancer.2017.721","volume":"11","author":"TG Shrihari","year":"2017","unstructured":"Shrihari TG. Dual role of inflammatory mediators in cancer. Ecancermedicalscience. 2017;11:721.","journal-title":"Ecancermedicalscience"},{"key":"1232_CR277","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9294018","volume":"2017","author":"GJ Szebeni","year":"2017","unstructured":"Szebeni GJ, Vizler C, Kitajka K, Puskas LG. Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters. Mediators Inflamm. 2017;2017:9294018.","journal-title":"Mediators Inflamm"},{"key":"1232_CR278","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1084\/jem.20080108","volume":"205","author":"T Hagemann","year":"2008","unstructured":"Hagemann T, Lawrence T, McNeish I, Charles KA, Kulbe H, Thompson RG, et al. Re-educating\u2019 tumor-associated macrophages by targeting NF-kappaB. J Exp Med. 2008;205:1261\u20138.","journal-title":"J Exp Med"},{"key":"1232_CR279","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.2147\/CMAR.S174899","volume":"10","author":"J Shen","year":"2018","unstructured":"Shen J, Sun X, Pan B, Cao S, Cao J, Che D, et al. IL-17 induces macrophages to M2-like phenotype via NF-\u03baB. Cancer Manag Res. 2018;10:4217\u201328.","journal-title":"Cancer Manag Res"},{"key":"1232_CR280","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.4049\/jimmunol.1402550","volume":"194","author":"APR Bally","year":"2015","unstructured":"Bally APR, Lu P, Tang Y, Austin JW, Scharer CD, Ahmed R, et al. NF-\u03baB Regulates PD-1 Expression in Macrophages. J Immunol. 2015;194:4545\u201354.","journal-title":"J Immunol"},{"key":"1232_CR281","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02791-0","volume":"21","author":"S Wang","year":"2023","unstructured":"Wang S, Kuai Y, Lin S, Li L, Gu Q, Zhang X, et al. NF-\u03baB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer. BMC Med. 2023;21:115.","journal-title":"BMC Med"},{"key":"1232_CR282","doi-asserted-by":"publisher","first-page":"30628","DOI":"10.1073\/pnas.2009778117","volume":"117","author":"RA Irizarry-Caro","year":"2020","unstructured":"Irizarry-Caro RA, McDaniel MM, Overcast GR, Jain VG, Troutman TD, Pasare C. TLR signaling adapter BCAP regulates inflammatory to reparatory macrophage transition by promoting histone lactylation. Proc Natl Acad Sci USA. 2020;117:30628\u201338.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1232_CR283","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.kint.2024.04.016","volume":"106","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li H, Jiang S, Fu D, Lu X, Lu M, et al. The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-\u03baB family activation. Kidney Int. 2024;106:226\u201340.","journal-title":"Kidney Int"},{"key":"1232_CR284","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02879-7","volume":"20","author":"L Wei","year":"2023","unstructured":"Wei L, Yang X, Wang J, Wang Z, Wang Q, Ding Y, et al. H3K18 lactylation of senescent microglia potentiates brain aging and Alzheimer\u2019s disease through the NF\u03baB signaling pathway. J Neuroinflammation. 2023;20:208.","journal-title":"J Neuroinflammation"},{"key":"1232_CR285","doi-asserted-by":"publisher","first-page":"e0145342","DOI":"10.1371\/journal.pone.0145342","volume":"10","author":"KA Jablonski","year":"2015","unstructured":"Jablonski KA, Amici SA, Webb LM, Ruiz-Rosado JdeD, Popovich PG, Partida-Sanchez S, et al. Novel Markers to Delineate Murine M1 and M2 Macrophages. PLoS One. 2015;10:e0145342.","journal-title":"PLoS One"},{"key":"1232_CR286","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1182\/blood-2011-02-339911","volume":"119","author":"OM Pello","year":"2012","unstructured":"Pello OM, De Pizzol M, Mirolo M, Soucek L, Zammataro L, Amabile A, et al. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology. Blood. 2012;119:411\u201321.","journal-title":"Blood"},{"key":"1232_CR287","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0818-0","volume":"9","author":"Y Yang","year":"2018","unstructured":"Yang Y, Ye Y-C, Chen Y, Zhao J-L, Gao C-C, Han H, et al. Crosstalk between hepatic tumor cells and macrophages via Wnt\/\u03b2-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors. Cell Death Dis. 2018;9:793.","journal-title":"Cell Death Dis"},{"key":"1232_CR288","doi-asserted-by":"publisher","first-page":"e45399","DOI":"10.1371\/journal.pone.0045399","volume":"7","author":"OM Pello","year":"2012","unstructured":"Pello OM, Ch\u00e8vre R, Laoui D, De Juan A, Lolo F, Andr\u00e9s-Manzano MJ, et al. In Vivo Inhibition of c-MYC in Myeloid Cells Impairs Tumor-Associated Macrophage Maturation and Pro-Tumoral Activities. PLoS One. 2012;7:e45399.","journal-title":"PLoS One"},{"key":"1232_CR289","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101758","volume":"37","author":"MR Pandkar","year":"2023","unstructured":"Pandkar MR, Sinha S, Samaiya A, Shukla S. Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression. Transl Oncol. 2023;37:101758.","journal-title":"Transl Oncol"},{"key":"1232_CR290","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1089\/jir.2016.0004","volume":"36","author":"A Mancino","year":"2016","unstructured":"Mancino A, Natoli G. Specificity and Function of IRF Family Transcription Factors: Insights from Genomics. J Interferon Cytokine Res. 2016;36:462\u20139.","journal-title":"J Interferon Cytokine Res"},{"key":"1232_CR291","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55378-2","volume":"9","author":"T Jeyakumar","year":"2019","unstructured":"Jeyakumar T, Fodil N, Van Der Kraak L, Meunier C, Cayrol R, McGregor K, et al. Inactivation of Interferon Regulatory Factor 1 Causes Susceptibility to Colitis-Associated Colorectal Cancer. Sci Rep. 2019;9:18897.","journal-title":"Sci Rep."},{"key":"1232_CR292","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.imbio.2017.10.005","volume":"223","author":"DA Chistiakov","year":"2018","unstructured":"Chistiakov DA, Myasoedova VA, Revin VV, Orekhov AN, Bobryshev YV. The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2. Immunobiology. 2018;223:101\u201311.","journal-title":"Immunobiology"},{"key":"1232_CR293","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/ni.1920","volume":"11","author":"T Satoh","year":"2010","unstructured":"Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol. 2010;11:936\u201344.","journal-title":"Nat Immunol"},{"key":"1232_CR294","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11911-5","volume":"10","author":"F Zhang","year":"2019","unstructured":"Zhang F, Parayath NN, Ene CI, Stephan SB, Koehne AL, Coon ME, et al. Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers. Nat Commun. 2019;10:3974.","journal-title":"Nat Commun"},{"key":"1232_CR295","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-187","volume":"8","author":"L Tarassishin","year":"2011","unstructured":"Tarassishin L, Suh H-S, Lee SC. Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K\/Akt pathway. J Neuroinflammation. 2011;8:187.","journal-title":"J Neuroinflammation"},{"key":"1232_CR296","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109636","volume":"121","author":"H Zhuang","year":"2020","unstructured":"Zhuang H, Dai X, Zhang X, Mao Z, Huang H. Sophoridine suppresses macrophage-mediated immunosuppression through TLR4\/IRF3 pathway and subsequently upregulates CD8+ T cytotoxic function against gastric cancer. Biomed Pharmacother. 2020;121:109636.","journal-title":"Biomed Pharmacother"},{"key":"1232_CR297","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.apjtm.2016.03.019","volume":"9","author":"B Liu","year":"2016","unstructured":"Liu B, Wang X, Chen T-Z, Li G-L, Tan C-C, Chen Y, et al. Polarization of M1 tumor associated macrophage promoted by the activation of TLR3 signal pathway. Asian Pac J Trop Med. 2016;9:484\u20138.","journal-title":"Asian Pac J Trop Med"},{"key":"1232_CR298","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/intimm\/dxr126","volume":"24","author":"Y Sugiyama","year":"2012","unstructured":"Sugiyama Y, Kakoi K, Kimura A, Takada I, Kashiwagi I, Wakabayashi Y, et al. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways. Int Immunol. 2012;24:253\u201365.","journal-title":"Int Immunol"},{"key":"1232_CR299","doi-asserted-by":"publisher","first-page":"e0159329","DOI":"10.1371\/journal.pone.0159329","volume":"11","author":"M Pinilla-Vera","year":"2016","unstructured":"Pinilla-Vera M, Xiong Z, Zhao Y, Zhao J, Donahoe MP, Barge S, et al. Full Spectrum of LPS Activation in Alveolar Macrophages of Healthy Volunteers by Whole Transcriptomic Profiling. PLoS One. 2016;11:e0159329.","journal-title":"PLoS One"},{"key":"1232_CR300","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/ni.1990","volume":"12","author":"T Krausgruber","year":"2011","unstructured":"Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011;12:231\u20138.","journal-title":"Nat Immunol"},{"key":"1232_CR301","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/1751-2980.13218","volume":"24","author":"Y Fang","year":"2023","unstructured":"Fang Y, Lu ZH, Liu BZ, Li N, Yang MZ, Wang P. IRF5 promotes glycolysis in the progression of hepatocellular carcinoma and is regulated by TRIM35. J Dig Dis. 2023;24:480\u201390.","journal-title":"J Dig Dis"},{"key":"1232_CR302","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12865-018-0261-0","volume":"19","author":"S Pavlou","year":"2018","unstructured":"Pavlou S, Lindsay J, Ingram R, Xu H, Chen M. Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity. BMC Immunol. 2018;19:24.","journal-title":"BMC Immunol"},{"key":"1232_CR303","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2017.06.004","volume":"26","author":"G Andrejeva","year":"2017","unstructured":"Andrejeva G, Rathmell JC. Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors. Cell Metab. 2017;26:49\u201370.","journal-title":"Cell Metab"},{"key":"1232_CR304","doi-asserted-by":"publisher","first-page":"501852","DOI":"10.3389\/fimmu.2019.02993","volume":"10","author":"A Batista-Gonzalez","year":"2020","unstructured":"Batista-Gonzalez A, Vidal R, Criollo A, Carre\u00f1o LJ. New Insights on the Role of Lipid Metabolism in the Metabolic Reprogramming of Macrophages. Front Immunol. 2020;10:501852.","journal-title":"Front Immunol"},{"key":"1232_CR305","doi-asserted-by":"publisher","unstructured":"Goossens P, Rodriguez-Vita J, Etzerodt A, Masse M, Rastoin O, Gouirand V, et al. Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression. Cell Metab 2019;29. https:\/\/doi.org\/10.1016\/J.CMET.2019.02.016.","DOI":"10.1016\/J.CMET.2019.02.016"},{"key":"1232_CR306","doi-asserted-by":"publisher","unstructured":"Saha P, Ettel P, Weichhart T. Leveraging macrophage metabolism for anticancer therapy: opportunities and pitfalls. Trends Pharmacol Sci 2024;45. https:\/\/doi.org\/10.1016\/J.TIPS.2024.02.005.","DOI":"10.1016\/J.TIPS.2024.02.005"},{"key":"1232_CR307","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh K, Shinde RS, Kl\u00f6tgen A, Halaby MJ, Lamorte S, Ciudad MT, et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55:324\u201340.e8.","journal-title":"Immunity"},{"key":"1232_CR308","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1146\/annurev-cancerbio-030419-033635","volume":"4","author":"BJ Van den Eynde","year":"2020","unstructured":"Van den Eynde BJ, van Baren N, Baurain J-F. Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma? Annu Rev Cancer Biol. 2020;4:241\u201356.","journal-title":"Annu Rev Cancer Biol"},{"key":"1232_CR309","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13046-017-0528-y","volume":"36","author":"P Zheng","year":"2017","unstructured":"Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie G, et al. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells. J Exp Clin Cancer Res. 2017;36:53.","journal-title":"J Exp Clin Cancer Res"},{"key":"1232_CR310","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1101\/gad.180331.111","volume":"25","author":"T Shree","year":"2011","unstructured":"Shree T, Olson OC, Elie BT, Kester JC, Garfall AL, Simpson K, et al. Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Genes Dev. 2011;25:2465\u201379.","journal-title":"Genes Dev"},{"key":"1232_CR311","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1158\/2326-6066.CIR-20-0968","volume":"9","author":"O Heath","year":"2021","unstructured":"Heath O, Berlato C, Maniati E, Lakhani A, Pegrum C, Kotantaki P, et al. Chemotherapy Induces Tumor-Associated Macrophages that Aid Adaptive Immune Responses in Ovarian Cancer. Cancer Immunol Res. 2021;9:665\u201381.","journal-title":"Cancer Immunol Res"},{"key":"1232_CR312","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1158\/1078-0432.CCR-21-2834","volume":"28","author":"M Liu","year":"2022","unstructured":"Liu M, Tayob N, Penter L, Sellars M, Tarren A, Chea V, et al. Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer. Clin Cancer Res. 2022;28:3356\u201366.","journal-title":"Clin Cancer Res"},{"key":"1232_CR313","doi-asserted-by":"publisher","first-page":"e1342918","DOI":"10.1080\/2162402X.2017.1342918","volume":"6","author":"A Malesci","year":"2017","unstructured":"Malesci A, Bianchi P, Celesti G, Basso G, Marchesi F, Grizzi F, et al. Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer. Oncoimmunology. 2017;6:e1342918.","journal-title":"Oncoimmunology"},{"key":"1232_CR314","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1049023","volume":"2017","author":"V Kaewkangsadan","year":"2017","unstructured":"Kaewkangsadan V, Verma C, Eremin JM, Cowley G, Ilyas M, Satthaporn S, et al. The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers. J Immunol Res. 2017;2017:1049023.","journal-title":"J Immunol Res"},{"key":"1232_CR315","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40425-018-0368-0","volume":"6","author":"ER Parra","year":"2018","unstructured":"Parra ER, Villalobos P, Behrens C, Jiang M, Pataer A, Swisher SG, et al. Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches. J Immunother Cancer. 2018;6:48.","journal-title":"J Immunother Cancer"},{"key":"1232_CR316","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","volume":"30","author":"YR Murciano-Goroff","year":"2020","unstructured":"Murciano-Goroff YR, Warner AB, Wolchok JD. The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Res. 2020;30:507\u201319.","journal-title":"Cell Res"},{"key":"1232_CR317","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/med.21765","volume":"41","author":"H Sadeghi Rad","year":"2021","unstructured":"Sadeghi Rad H, Monkman J, Warkiani ME, Ladwa R, O\u2019Byrne K, Rezaei N, et al. Understanding the tumor microenvironment for effective immunotherapy. Med Res Rev. 2021;41:1474\u201398.","journal-title":"Med Res Rev"},{"key":"1232_CR318","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.242","volume":"4","author":"C Xu","year":"2023","unstructured":"Xu C, Xia Y, Zhang B-W, Drokow EK, Li H-Y, Xu S, et al. Macrophages facilitate tumor cell PD-L1 expression via an IL-1\u03b2-centered loop to attenuate immune checkpoint blockade. MedComm (Beijing). 2023;4:e242.","journal-title":"MedComm (Beijing)"},{"key":"1232_CR319","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112315","volume":"396","author":"X Ju","year":"2020","unstructured":"Ju X, Zhang H, Zhou Z, Chen M, Wang Q. Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-\u0251 signaling. Exp Cell Res. 2020;396:112315.","journal-title":"Exp Cell Res"},{"key":"1232_CR320","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2063225","volume":"11","author":"K Kos","year":"2022","unstructured":"Kos K, Salvagno C, Wellenstein MD, Aslam MA, Meijer DA, Hau C-S, et al. Tumor-associated macrophages promote intratumoral conversion of conventional CD4+ T cells into regulatory T cells via PD-1 signalling. Oncoimmunology. 2022;11:2063225.","journal-title":"Oncoimmunology"},{"key":"1232_CR321","doi-asserted-by":"publisher","unstructured":"Larroquette M, Guegan J-P, Besse B, Cousin S, Brunet M, Le Moulec S, et al. Spatial transcriptomics of macrophage infiltration in non-small cell lung cancer reveals determinants of sensitivity and resistance to anti-PD1\/PD-L1 antibodies. J Immunother Cancer 2022;10. https:\/\/doi.org\/10.1136\/jitc-2021-003890.","DOI":"10.1136\/jitc-2021-003890"},{"key":"1232_CR322","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2022.07.004","volume":"67","author":"W Li","year":"2022","unstructured":"Li W, Wu F, Zhao S, Shi P, Wang S, Cui D. Correlation between PD-1\/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy. Cytokine Growth Factor Rev. 2022;67:49\u201357.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1232_CR323","first-page":"59","volume":"865","author":"A Mantovani","year":"1986","unstructured":"Mantovani A, Ming WJ, Balotta C, Abdeljalil B, Bottazzi B. Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor. Biochim Biophys Acta. 1986;865:59\u201367.","journal-title":"Biochim Biophys Acta"},{"key":"1232_CR324","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19:369\u201382.","journal-title":"Nat Rev Immunol"},{"key":"1232_CR325","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21:799\u2013820.","journal-title":"Nat Rev Drug Discov"},{"key":"1232_CR326","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1182\/blood-2011-09-379214","volume":"119","author":"DA Hume","year":"2012","unstructured":"Hume DA, MacDonald KPA. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood. 2012;119:1810\u201320.","journal-title":"Blood"},{"key":"1232_CR327","doi-asserted-by":"publisher","first-page":"105","DOI":"10.36401\/JIPO-20-32","volume":"4","author":"C-C Lin","year":"2021","unstructured":"Lin C-C. Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitors. J Immunother Precis Oncol. 2021;4:105\u201314.","journal-title":"J Immunother Precis Oncol"},{"key":"1232_CR328","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101514","volume":"54","author":"P Ordentlich","year":"2021","unstructured":"Ordentlich P. Clinical evaluation of colony-stimulating factor 1 receptor inhibitors. Semin Immunol. 2021;54:101514.","journal-title":"Semin Immunol"},{"key":"1232_CR329","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/bs.apha.2021.03.002","volume":"91","author":"RK Rasmussen","year":"2021","unstructured":"Rasmussen RK, Etzerodt A. Therapeutic targeting of tumor-associated macrophages. Adv Pharm. 2021;91:185\u2013211.","journal-title":"Adv Pharm"},{"key":"1232_CR330","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114884","volume":"245","author":"J Wen","year":"2023","unstructured":"Wen J, Wang S, Guo R, Liu D. CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment. Eur J Med Chem. 2023;245:114884.","journal-title":"Eur J Med Chem"},{"key":"1232_CR331","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2147\/DDDT.S253232","volume":"14","author":"B Benner","year":"2020","unstructured":"Benner B, Good L, Quiroga D, Schultz TE, Kassem M, Carson WE, et al. Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development. Drug Des Devel Ther. 2020;14:1693\u2013704.","journal-title":"Drug Des Devel Ther"},{"key":"1232_CR332","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ccr.2014.05.016","volume":"25","author":"CH Ries","year":"2014","unstructured":"Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V, et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell. 2014;25:846\u201359.","journal-title":"Cancer Cell"},{"key":"1232_CR333","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S1470-2045(15)00132-1","volume":"16","author":"PA Cassier","year":"2015","unstructured":"Cassier PA, Italiano A, Gomez-Roca CA, Le Tourneau C, Toulmonde M, Cannarile MA, et al. CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study. Lancet Oncol. 2015;16:949\u201356.","journal-title":"Lancet Oncol"},{"key":"1232_CR334","doi-asserted-by":"publisher","DOI":"10.1186\/2051-1426-3-S2-P351","volume":"3","author":"D Bellovin","year":"2015","unstructured":"Bellovin D, Wondyfraw N, Levin A, DeNardo DG, Masteller E, Brennan T. cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models. J Immunother Cancer. 2015;3:P351.","journal-title":"J Immunother Cancer"},{"key":"1232_CR335","doi-asserted-by":"publisher","first-page":"11078","DOI":"10.1200\/JCO.2017.35.15_suppl.11078","volume":"35","author":"KK Sankhala","year":"2017","unstructured":"Sankhala KK, Blay J-Y, Ganjoo KN, Italiano A, Hassan AB, Kim TM, et al. A phase I\/II dose escalation and expansion study of cabiralizumab (cabira; FPA-008), an anti-CSF1R antibody, in tenosynovial giant cell tumor (TGCT, diffuse pigmented villonodular synovitis D-PVNS). J Clin Oncol. 2017;35:11078.","journal-title":"J Clin Oncol"},{"key":"1232_CR336","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/ijc.31532","volume":"143","author":"MW Webb","year":"2018","unstructured":"Webb MW, Sun J, Sheard MA, Liu W-Y, Wu H-W, Jackson JR, et al. Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes. Int J Cancer. 2018;143:1483\u201393.","journal-title":"Int J Cancer"},{"key":"1232_CR337","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1158\/1078-0432.CCR-20-3955","volume":"28","author":"S Kuemmel","year":"2022","unstructured":"Kuemmel S, Campone M, Loirat D, Lopez RL, Beck JT, De Laurentiis M, et al. A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer. Clin Cancer Res. 2022;28:106\u201315.","journal-title":"Clin Cancer Res"},{"key":"1232_CR338","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/84209","volume":"2","author":"C Gerard","year":"2001","unstructured":"Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol. 2001;2:108\u201315.","journal-title":"Nat Immunol"},{"key":"1232_CR339","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23\u201335.","journal-title":"Nat Rev Immunol"},{"key":"1232_CR340","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides A, Strauss L, Yeo A, Cao C, Charest A, Boussiotis VA. The complex role of tumor-infiltrating macrophages. Nat Immunol. 2022;23:1148\u201356.","journal-title":"Nat Immunol"},{"key":"1232_CR341","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496:445\u201355.","journal-title":"Nature"},{"key":"1232_CR342","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1593\/neo.07871","volume":"10","author":"JC Pahler","year":"2008","unstructured":"Pahler JC, Tazzyman S, Erez N, Chen Y-Y, Murdoch C, Nozawa H, et al. Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. Neoplasia. 2008;10:329\u201340.","journal-title":"Neoplasia"},{"key":"1232_CR343","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ijc.21371","volume":"118","author":"X Yang","year":"2006","unstructured":"Yang X, Lu P, Ishida Y, Kuziel WA, Fujii C, Mukaida N. Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization. Int J Cancer. 2006;118:335\u201345.","journal-title":"Int J Cancer"},{"key":"1232_CR344","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrd2734","volume":"8","author":"R Horuk","year":"2009","unstructured":"Horuk R. Chemokine receptor antagonists: overcoming developmental hurdles. Nat Rev Drug Discov. 2009;8:23\u201333.","journal-title":"Nat Rev Drug Discov"},{"key":"1232_CR345","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14:399\u2013416.","journal-title":"Nat Rev Clin Oncol"},{"key":"1232_CR346","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1073\/pnas.1910856117","volume":"117","author":"JA Flores-Toro","year":"2020","unstructured":"Flores-Toro JA, Luo D, Gopinath A, Sarkisian MR, Campbell JJ, Charo IF, et al. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas. Proc Natl Acad Sci USA. 2020;117:1129\u201338.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1232_CR347","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s10637-012-9869-8","volume":"31","author":"KJ Pienta","year":"2013","unstructured":"Pienta KJ, Machiels J-P, Schrijvers D, Alekseev B, Shkolnik M, Crabb SJ, et al. Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer. Invest N. Drugs. 2013;31:760\u20138.","journal-title":"Invest N. Drugs"},{"key":"1232_CR348","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00280-013-2099-8","volume":"71","author":"SK Sandhu","year":"2013","unstructured":"Sandhu SK, Papadopoulos K, Fong PC, Patnaik A, Messiou C, Olmos D, et al. A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors. Cancer Chemother Pharm. 2013;71:1041\u201350.","journal-title":"Cancer Chemother Pharm"},{"key":"1232_CR349","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11523-014-0320-2","volume":"10","author":"I Brana","year":"2015","unstructured":"Brana I, Calles A, LoRusso PM, Yee LK, Puchalski TA, Seetharam S, et al. Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study. Target Oncol. 2015;10:111\u201323.","journal-title":"Target Oncol"},{"key":"1232_CR350","doi-asserted-by":"publisher","unstructured":"Raghu G, Martinez FJ, Brown KK, Costabel U, Cottin V, Wells AU et al. CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab. Eur Respir J. 2015;46. https:\/\/doi.org\/10.1183\/13993003.01558-2014.","DOI":"10.1183\/13993003.01558-2014"},{"key":"1232_CR351","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1166487","volume":"14","author":"SU Khan","year":"2023","unstructured":"Khan SU, Khan MU, Azhar Ud Din M, Khan IM, Khan MI, Bungau S, et al. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy. Front Immunol. 2023;14:1166487.","journal-title":"Front Immunol"},{"key":"1232_CR352","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1182\/blood-2005-01-0428","volume":"107","author":"SK Biswas","year":"2006","unstructured":"Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3\/STAT1 activation). Blood. 2006;107:2112\u201322.","journal-title":"Blood"},{"key":"1232_CR353","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1160719","volume":"14","author":"T Xia","year":"2023","unstructured":"Xia T, Zhang M, Lei W, Yang R, Fu S, Fan Z, et al. Advances in the role of STAT3 in macrophage polarization. Front Immunol. 2023;14:1160719.","journal-title":"Front Immunol"},{"key":"1232_CR354","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.canlet.2013.02.010","volume":"335","author":"M-J Kim","year":"2013","unstructured":"Kim M-J, Nam H-J, Kim H-P, Han S-W, Im S-A, Kim T-Y, et al. OPB-31121, a novel small molecular inhibitor, disrupts the JAK2\/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells. Cancer Lett. 2013;335:145\u201352.","journal-title":"Cancer Lett"},{"key":"1232_CR355","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1038\/bcj.2013.63","volume":"3","author":"F Hayakawa","year":"2013","unstructured":"Hayakawa F, Sugimoto K, Harada Y, Hashimoto N, Ohi N, Kurahashi S, et al. A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases. Blood Cancer J. 2013;3:e166.","journal-title":"Blood Cancer J"},{"key":"1232_CR356","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.molonc.2015.02.012","volume":"9","author":"L Brambilla","year":"2015","unstructured":"Brambilla L, Genini D, Laurini E, Merulla J, Perez L, Fermeglia M, et al. Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3). Mol Oncol. 2015;9:1194\u2013206.","journal-title":"Mol Oncol"},{"key":"1232_CR357","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/eji.201344130","volume":"44","author":"F Bellora","year":"2014","unstructured":"Bellora F, Castriconi R, Dondero A, Pessino A, Nencioni A, Liggieri G, et al. TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells. Eur J Immunol. 2014;44:1814\u201322.","journal-title":"Eur J Immunol"},{"key":"1232_CR358","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6444","volume":"5","author":"LTC Vogelpoel","year":"2014","unstructured":"Vogelpoel LTC, Hansen IS, Rispens T, Muller FJM, van Capel TMM, Turina MC, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5:5444.","journal-title":"Nat Commun"},{"key":"1232_CR359","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","volume":"2","author":"CB Rodell","year":"2018","unstructured":"Rodell CB, Arlauckas SP, Cuccarese MF, Garris CS, Li R, Ahmed MS, et al. TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy. Nat Biomed Eng. 2018;2:578\u201388.","journal-title":"Nat Biomed Eng"},{"key":"1232_CR360","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202307694","volume":"20","author":"YJ Yoo","year":"2024","unstructured":"Yoo YJ, Eun R, Park HM, Kim S, Park SH, Heo J, et al. Nanoengineered Macrophages Armed with TLR7\/8 Agonist Enhance Remodeling of Immunosuppressive Tumor Microenvironment. Small. 2024;20:e2307694.","journal-title":"Small"},{"key":"1232_CR361","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1039\/D3SC06431J","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Liu Y, Jiang M, Mas-Rosario JA, Fedeli S, Cao-Milan R, et al. Polarization of macrophages to an anti-cancer phenotype through in situ uncaging of a TLR 7\/8 agonist using bioorthogonal nanozymes. Chem Sci. 2024;15:2486\u201394.","journal-title":"Chem Sci"},{"key":"1232_CR362","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s40425-019-0811-x","volume":"7","author":"MJ Reilley","year":"2019","unstructured":"Reilley MJ, Morrow B, Ager CR, Liu A, Hong DS, Curran MA. TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma. J Immunother Cancer. 2019;7:323.","journal-title":"J Immunother Cancer"},{"key":"1232_CR363","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/annonc\/mdx049","volume":"28","author":"BJ Monk","year":"2017","unstructured":"Monk BJ, Brady MF, Aghajanian C, Lankes HA, Rizack T, Leach J, et al. A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. Ann Oncol. 2017;28:996\u20131004.","journal-title":"Ann Oncol"},{"key":"1232_CR364","doi-asserted-by":"publisher","first-page":"39.e1","DOI":"10.1016\/j.urolonc.2016.09.006","volume":"35","author":"NM Donin","year":"2017","unstructured":"Donin NM, Chamie K, Lenis AT, Pantuck AJ, Reddy M, Kivlin D, et al. A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer. Urol Oncol. 2017;35:39.e1\u201339.e7.","journal-title":"Urol Oncol"},{"key":"1232_CR365","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/jb\/mvu017","volume":"155","author":"Y Murata","year":"2014","unstructured":"Murata Y, Kotani T, Ohnishi H, Matozaki T. The CD47-SIRP\u03b1 signalling system: its physiological roles and therapeutic application. J Biochem. 2014;155:335\u201344.","journal-title":"J Biochem"},{"key":"1232_CR366","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imr.12527","volume":"276","author":"HL Matlung","year":"2017","unstructured":"Matlung HL, Szilagyi K, Barclay NA, van den Berg TK. The CD47-SIRP\u03b1 signaling axis as an innate immune checkpoint in cancer. Immunol Rev. 2017;276:145\u201364.","journal-title":"Immunol Rev"},{"key":"1232_CR367","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","volume":"574","author":"O Demaria","year":"2019","unstructured":"Demaria O, Cornen S, Da\u00ebron M, Morel Y, Medzhitov R, Vivier E. Harnessing innate immunity in cancer therapy. Nature. 2019;574:45\u201356.","journal-title":"Nature"},{"key":"1232_CR368","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.it.2017.12.005","volume":"39","author":"A Veillette","year":"2018","unstructured":"Veillette A, Chen J. SIRP\u03b1-CD47 Immune Checkpoint Blockade in Anticancer Therapy. Trends Immunol. 2018;39:173\u201384.","journal-title":"Trends Immunol"},{"key":"1232_CR369","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg MEW, Scheeren FA, Schumacher TN. The CD47-SIRP\u03b1 Immune Checkpoint. Immunity. 2020;52:742\u201352.","journal-title":"Immunity"},{"key":"1232_CR370","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","volume":"20","author":"SP Kubli","year":"2021","unstructured":"Kubli SP, Berger T, Araujo DV, Siu LL, Mak TW. Beyond immune checkpoint blockade: emerging immunological strategies. Nat Rev Drug Discov. 2021;20:899\u2013919.","journal-title":"Nat Rev Drug Discov"},{"key":"1232_CR371","doi-asserted-by":"publisher","first-page":"451543","DOI":"10.3389\/fimmu.2019.01084","volume":"10","author":"M Orecchioni","year":"2019","unstructured":"Orecchioni M, Ghosheh Y, Pramod AB, Ley K. Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS\u2013) vs. Alternatively Activated Macrophages. Front Immunol. 2019;10:451543.","journal-title":"Front Immunol"},{"key":"1232_CR372","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41590-023-01430-3","volume":"24","author":"P-S Liu","year":"2023","unstructured":"Liu P-S, Chen Y-T, Li X, Hsueh P-C, Tzeng S-F, Chen H, et al. CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions. Nat Immunol. 2023;24:452\u201362.","journal-title":"Nat Immunol"},{"key":"1232_CR373","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev. 2009;229:152\u201372.","journal-title":"Immunol Rev"},{"key":"1232_CR374","doi-asserted-by":"crossref","unstructured":"Fenis A, Demaria O, Gauthier L, Vivier E, Narni-Mancinelli E. New immune cell engagers for cancer immunotherapy. Nat Rev Immunol. 2024;24:471\u201386.","DOI":"10.1038\/s41577-023-00982-7"},{"key":"1232_CR375","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1126\/science.1198443","volume":"331","author":"GL Beatty","year":"2011","unstructured":"Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science. 2011;331:1612\u20136.","journal-title":"Science"},{"key":"1232_CR376","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrd.2018.75","volume":"17","author":"PA Mayes","year":"2018","unstructured":"Mayes PA, Hance KW, Hoos A. The promise and challenges of immune agonist antibody development in cancer. Nat Rev Drug Discov. 2018;17:509\u201327.","journal-title":"Nat Rev Drug Discov"},{"key":"1232_CR377","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17:887\u2013904.","journal-title":"Nat Rev Drug Discov"},{"key":"1232_CR378","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106327","volume":"183","author":"FM Frank","year":"2023","unstructured":"Frank FM, Wagner DH, Postan M, Petray PB. Importance of CD40\/CD40 dyad in the course of infection with Trypanosoma cruzi: Impact of its inhibition. Micro Pathog. 2023;183:106327.","journal-title":"Micro Pathog"},{"key":"1232_CR379","doi-asserted-by":"publisher","unstructured":"Daub S, Lutgens E, M\u00fcnzel T, Daiber A. CD40\/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease-The Pros and Cons for Cardioprotection. Int J Mol Sci 2020;21. https:\/\/doi.org\/10.3390\/ijms21228533.","DOI":"10.3390\/ijms21228533"},{"key":"1232_CR380","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.103893","volume":"29","author":"C-Z Jian","year":"2024","unstructured":"Jian C-Z, Lin L, Hsu C-L, Chen Y-H, Hsu C, Tan C-T, et al. A potential novel cancer immunotherapy: Agonistic anti-CD40 antibodies. Drug Discov Today. 2024;29:103893.","journal-title":"Drug Discov Today"},{"key":"1232_CR381","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41423-021-00734-4","volume":"19","author":"TNJ Bullock","year":"2022","unstructured":"Bullock TNJ. CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies. Cell Mol Immunol. 2022;19:14\u201322.","journal-title":"Cell Mol Immunol"},{"key":"1232_CR382","doi-asserted-by":"publisher","unstructured":"Van den Bossche J, O\u2019Neill L, Menon D Macrophage Immunometabolism: Where Are We (Going)? Trends Immunol. 2017;38. https:\/\/doi.org\/10.1016\/J.IT.2017.03.001.","DOI":"10.1016\/J.IT.2017.03.001"},{"key":"1232_CR383","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.3390\/ijms22126350","volume":"22","author":"HL Penny","year":"2021","unstructured":"Penny HL, Sieow JL, Gun SY, Lau MC, Lee B, Tan J, et al. Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma. Int J Mol Sci. 2021;22:6350.","journal-title":"Int J Mol Sci"},{"key":"1232_CR384","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1158\/0008-5472.CAN-16-2938","volume":"77","author":"P Seth","year":"2017","unstructured":"Seth P, Csizmadia E, Hedblom A, Vuerich M, Xie H, Li M, et al. Deletion of Lactate Dehydrogenase-A in Myeloid Cells Triggers Antitumor Immunity. Cancer Res. 2017;77:3632\u201343.","journal-title":"Cancer Res"},{"key":"1232_CR385","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer. 2016;16:635\u201349.","journal-title":"Nat Rev Cancer"},{"key":"1232_CR386","first-page":"265","volume":"28","author":"PE Porporato","year":"2017","unstructured":"Porporato PE, Filigheddu N, Pedro JMB-S, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Res 2017 28:3. 2017;28:265\u201380.","journal-title":"Cell Res 2017 28:3"},{"key":"1232_CR387","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","volume":"80","author":"P Su","year":"2020","unstructured":"Su P, Wang Q, Bi E, Ma X, Liu L, Yang M, et al. Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages. Cancer Res. 2020;80:1438\u201350.","journal-title":"Cancer Res"},{"key":"1232_CR388","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/abbs\/gmu042","volume":"46","author":"G Zhang","year":"2014","unstructured":"Zhang G, Zhang H, Liu Y, He Y, Wang W, Du Y, et al. CD44 clustering is involved in monocyte differentiation. Acta Biochim Biophys Sin (Shanghai). 2014;46:540\u20137.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1232_CR389","doi-asserted-by":"publisher","first-page":"80046","DOI":"10.18632\/oncotarget.11098","volume":"7","author":"CW Menke-van der Houven van Oordt","year":"2016","unstructured":"Menke-van der Houven van Oordt CW, Gomez-Roca C, van Herpen C, Coveler AL, Mahalingam D, Verheul HMW, et al. First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors. Oncotarget. 2016;7:80046\u201358.","journal-title":"Oncotarget"},{"key":"1232_CR390","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","volume":"20","author":"GV Long","year":"2019","unstructured":"Long GV, Dummer R, Hamid O, Gajewski TF, Caglevic C, Dalle S, et al. Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study. Lancet Oncol. 2019;20:1083\u201397.","journal-title":"Lancet Oncol"},{"key":"1232_CR391","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jlb.64.4.419","volume":"64","author":"R Andreesen","year":"1998","unstructured":"Andreesen R, Hennemann B, Krause SW. Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives. J Leukoc Biol. 1998;64:419\u201326.","journal-title":"J Leukoc Biol"},{"key":"1232_CR392","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000163658","volume":"59","author":"R Andreesen","year":"1991","unstructured":"Andreesen R, Hennemann B. Adoptive immunotherapy with autologous macrophages: current status and future perspectives. Pathobiology. 1991;59:259\u201363.","journal-title":"Pathobiology"},{"key":"1232_CR393","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/00002371-199709000-00005","volume":"20","author":"B Hennemann","year":"1997","unstructured":"Hennemann B, Rehm A, Kottke A, Meidenbauer N, Andreesen R. Adoptive immunotherapy with tumor-cytotoxic macrophages derived from recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) mobilized peripheral blood monocytes. J Immunother. 1997;20:365\u201371.","journal-title":"J Immunother"},{"key":"1232_CR394","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1189\/jlb.0504272","volume":"76","author":"RD Stout","year":"2004","unstructured":"Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol. 2004;76:509\u201313.","journal-title":"J Leukoc Biol"},{"key":"1232_CR395","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.imbio.2006.05.017","volume":"211","author":"A Gratchev","year":"2006","unstructured":"Gratchev A, Kzhyshkowska J, K\u00f6the K, Muller-Molinet I, Kannookadan S, Utikal J, et al. Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology. 2006;211:473\u201386.","journal-title":"Immunobiology"},{"key":"1232_CR396","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.0105-2896.2005.00260.x","volume":"205","author":"RD Stout","year":"2005","unstructured":"Stout RD, Suttles J. Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol Rev. 2005;205:60\u201371.","journal-title":"Immunol Rev"},{"key":"1232_CR397","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1291619","volume":"14","author":"Y Liang","year":"2023","unstructured":"Liang Y, Xu Q, Gao Q. Advancing CAR-based immunotherapies in solid tumors: CAR- macrophages and neutrophils. Front Immunol. 2023;14:1291619.","journal-title":"Front Immunol"},{"key":"1232_CR398","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1158\/2326-6066.CIR-22-0030","volume":"10","author":"M Cannac","year":"2022","unstructured":"Cannac M, Nikolic J, Benaroch P. Cancer Immunotherapies Based on Genetically Engineered Macrophages. Cancer Immunol Res. 2022;10:1156\u201366.","journal-title":"Cancer Immunol Res"},{"key":"1232_CR399","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41590-023-01696-7","volume":"25","author":"SM Abdin","year":"2024","unstructured":"Abdin SM, Paasch D, Lachmann N. CAR macrophages on a fast track to solid tumor therapy. Nat Immunol. 2024;25:11\u201312.","journal-title":"Nat Immunol"},{"key":"1232_CR400","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.783305","volume":"12","author":"C Sloas","year":"2021","unstructured":"Sloas C, Gill S, Klichinsky M. Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors. Front Immunol. 2021;12:783305.","journal-title":"Front Immunol"},{"key":"1232_CR401","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","volume":"41","author":"K Pan","year":"2022","unstructured":"Pan K, Farrukh H, Chittepu VCSR, Xu H, Pan C-X, Zhu Z. CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy. J Exp Clin Cancer Res. 2022;41:119.","journal-title":"J Exp Clin Cancer Res"},{"key":"1232_CR402","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13045-020-00983-2","volume":"13","author":"L Zhang","year":"2020","unstructured":"Zhang L, Tian L, Dai X, Yu H, Wang J, Lei A, et al. Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions. J Hematol Oncol. 2020;13:153.","journal-title":"J Hematol Oncol"},{"key":"1232_CR403","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","volume":"25","author":"A Lei","year":"2024","unstructured":"Lei A, Yu H, Lu S, Lu H, Ding X, Tan T, et al. A second-generation M1-polarized CAR macrophage with antitumor efficacy. Nat Immunol. 2024;25:102\u201316.","journal-title":"Nat Immunol"},{"key":"1232_CR404","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.stemcr.2022.12.012","volume":"18","author":"J Zhang","year":"2023","unstructured":"Zhang J, Webster S, Duffin B, Bernstein MN, Steill J, Swanson S, et al. Generation of anti-GD2 CAR macrophages from human pluripotent stem cells for cancer immunotherapies. Stem Cell Rep. 2023;18:585\u201396.","journal-title":"Stem Cell Rep."},{"key":"1232_CR405","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ccr.2008.09.004","volume":"14","author":"M De Palma","year":"2008","unstructured":"De Palma M, Mazzieri R, Politi LS, Pucci F, Zonari E, Sitia G, et al. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell. 2008;14:299\u2013311.","journal-title":"Cancer Cell"},{"key":"1232_CR406","doi-asserted-by":"publisher","first-page":"217ra3","DOI":"10.1126\/scitranslmed.3006353","volume":"6","author":"G Escobar","year":"2014","unstructured":"Escobar G, Moi D, Ranghetti A, Ozkal-Baydin P, Squadrito ML, Kajaste-Rudnitski A, et al. Genetic engineering of hematopoiesis for targeted IFN-\u03b1 delivery inhibits breast cancer progression. Sci Transl Med. 2014;6:217ra3.","journal-title":"Sci Transl Med"},{"key":"1232_CR407","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","volume":"38","author":"M Klichinsky","year":"2020","unstructured":"Klichinsky M, Ruella M, Shestova O, Lu XM, Best A, Zeeman M, et al. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat Biotechnol. 2020;38:947\u201353.","journal-title":"Nat Biotechnol"},{"key":"1232_CR408","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.cell.2021.02.048","volume":"184","author":"S Kaczanowska","year":"2021","unstructured":"Kaczanowska S, Beury DW, Gopalan V, Tycko AK, Qin H, Clements ME, et al. Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis. Cell. 2021;184:2033\u201352.e21.","journal-title":"Cell"},{"key":"1232_CR409","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.ccell.2023.09.014","volume":"41","author":"T Kerzel","year":"2023","unstructured":"Kerzel T, Giacca G, Beretta S, Bresesti C, Notaro M, Scotti GM, et al. In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases. Cancer Cell. 2023;41:1892\u20131910.e10.","journal-title":"Cancer Cell"},{"key":"1232_CR410","doi-asserted-by":"publisher","unstructured":"Morrissey MA, Williamson AP, Steinbach AM, Roberts EW, Kern N, Headley MB et al. Chimeric antigen receptors that trigger phagocytosis. Elife 2018;7. https:\/\/doi.org\/10.7554\/eLife.36688.","DOI":"10.7554\/eLife.36688"},{"key":"1232_CR411","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cbpa.2020.04.020","volume":"57","author":"RAF Gjaltema","year":"2020","unstructured":"Gjaltema RAF, Rots MG. Advances of epigenetic editing. Curr Opin Chem Biol. 2020;57:75\u201381.","journal-title":"Curr Opin Chem Biol"},{"key":"1232_CR412","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/978-3-031-11454-0_18","volume":"1389","author":"FM Cort\u00e9s-Mancera","year":"2022","unstructured":"Cort\u00e9s-Mancera FM, Sarno F, Goubert D, Rots MG. Gene-Targeted DNA Methylation: Towards Long-Lasting Reprogramming of Gene Expression? Adv Exp Med Biol. 2022;1389:515\u201333.","journal-title":"Adv Exp Med Biol"},{"key":"1232_CR413","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2023.2175522","volume":"18","author":"D-D Wu","year":"2023","unstructured":"Wu D-D, Lau ATY, Xu Y-M, Reinders-Luinge M, Koncz M, Kiss A, et al. Targeted epigenetic silencing of UCHL1 expression suppresses collagen-1 production in human lung epithelial cells. Epigenetics. 2023;18:2175522.","journal-title":"Epigenetics"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01232-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T19:04:37Z","timestamp":1732907077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01232-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":413,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1232"],"URL":"https:\/\/doi.org\/10.1038\/s41423-024-01232-z","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}